Efferocytosis is an Innate Antibacterial Mechanism of Mycobacterium tuberculosis Control by Martin, Constance Jean
 
Efferocytosis is an Innate Antibacterial Mechanism of
Mycobacterium tuberculosis Control
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation No citation.
Accessed February 19, 2015 10:57:25 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10054147
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA 
Efferocytosis is an Innate Antibacterial Mechanism of  
Mycobacterium tuberculosis Control 
 
A dissertation presented  
by 
Constance Jean Martin 
to 
Biological Science and Public Health  
 
in partial fulfillment of the requirements 
for the degree of 
Doctor of Philosophy 
In the subject of 
Biological Science and Public Health 
 
Harvard University 
Cambridge, Massachusetts 
May 2012 
 
 
 
      
© 2012 – Constance Jean Martin 
All rights reserved. Dissertation Advisor: Samuel M. Behar    Constance J. Martin 
iii 
 
Efferocytosis is an innate antibacterial mechanism of 
Mycobacterium tuberculosis control 
 
Abstract 
  One third of the world’s population is infected with Mycobacterium tuberculosis, causing 
two million deaths annually.  The bacteria avoid immune clearance by persisting within 
macrophages by subverting normal phagosome maturation and acidification.  In order to spread, 
the bacteria induce necrotic death of its host macrophage, broadcasting the infection into 
neighboring cells.  However, it has long been appreciated that the apoptotic, rather than necrotic 
death of an infected macrophage results in bacterial growth suppression, improved adaptive 
immune response and survival.  The mechanism for apoptosis-mediated bacterial suppression has 
hitherto remained unknown. 
  In this dissertation we report that apoptosis itself is not intrinsically bactericidal.  We find 
that following apoptosis, the M. tuberculosis-infected macrophage is engulfed by bystander 
macrophages through the process of efferocytosis.  Efferocytosis, or apoptotic cell clearance, is a 
critical function of macrophages; however, little is known regarding efferocytosis of infected 
apoptotic cells.  We find that M. tuberculosis-infected macrophages die by apoptosis more 
commonly than found previously.   By confocal microscopy we observed that apoptotic 
macrophages are rapidly engulfed by uninfected macrophages.  Efferocytosis of M. tuberculosis-
infected macrophages occurs in vitro with all macrophage types tested and in vivo- specifically in 
the lung, indicating that efferocytosis could play an important role during infection.  We 
developed an uninfected macrophage co-culture system in which we observe efferocytosis and  
iv 
 
define conditions in which it occurs.  Using this co-culture system we observe a suppression of 
bacterial growth.  By blocking efferocytosis, we have found that the engulfment of infected cells 
is required for M. tuberculosis control in the macrophage co-culture system, demonstrating that 
efferocytosis is a novel antibacterial mechanism.  We then demonstrated using transmission 
electron microscopy that the M. tuberculosis-containing efferocytic phagosome is structurally 
distinct from the traditional M. tuberculosis phagosome.  Bacteria from within the efferocytic 
phagosome are unable to halt its maturation, and as such are delivered to lysosomes.  
Furthermore, we find that following efferocytosis, M. tuberculosis are killed.  While 
efferocytosis is recognized as a constitutive housekeeping function of macrophages, our work 
indicates that is should also be viewed as an antimicrobial effector mechanism. 
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Tuberculosis: A Global Problem 
Despite being an ancient disease, tuberculosis (TB) remains a disease of massive public 
health importance.  It is estimated that a third of the world’s population asymptomatically 
harbors Mycobacterium tuberculosis (Mtb), the causative agent, while 12-14 million fall ill each 
year
1.  An estimated 2 million people die from tuberculosis annually, ranking TB as one of the 
top infectious disease scourges.  TB largely strikes women and working age adults, making the 
disease a tremendous burden to developing economies and severally impacting children and 
families
2.  As such, there are an estimated 10 million children in the world orphaned by 
tuberculosis.    The majority of cases and deaths attributed to tuberculosis are found in Southeast 
Asia and Africa, where the high incidence of HIV has dramatically affected the population and is 
a major societal and public health problem.  And while for 2008, the WHO reported that the 
global incidence of new TB cases has dropped, TB is still on the rise in many parts of the world
1, 
2.   From a clinical and public health standpoint, tuberculosis is a difficult disease to treat, as 
patients are required to take antibiotics, some with harmful side effects, for 6-9 months or more
3.  
Adherence failure has been attributed to the rise in drug resistance, with some clinical isolates 
showing resistance to multiple antibiotics commonly used to treat TB.  Many first line drugs are 
obsolete in parts of the world, only compounding the difficulty of control of tuberculosis
4. 
Tuberculosis, the disease 
Tuberculosis most often manifests as a pulmonary infection in adults.  Children are more 
prone to serious systemic infections, including miliary tuberculosis and tuberculosis meningitis.  
Other common manifestations include infections of the joints, pleural cavity and lymph nodes.  
Symptoms of tuberculosis include fever and night sweats, loss of appetite and weight, and cough.  
In fact it is the wasting nature of the disease that gave it its original name- consumption.  Patients 3 
 
suffer from fatigue and reduced lung capacity as normal lung architecture succumbs to 
inflammation and granuloma formation.   It wasn’t until 1834 when Johann Lukas Schönlein 
associated the granulomatous mass that is the hallmark of TB or ‘tubercule’ in patients suffering 
from consumption with disease
5.  Mycobacterium tuberculosis as the bacterium responsible for 
disease was identified by Robert Koch in 1882.  The development of Koch’s Postulates, the 
foundation of infectious disease microbiology, which outlines how to define disease and its cause 
by an infectious agent was first demonstrated with Mtb.    
Tuberculosis is most often transmitted when an infected individual coughs, aerosolizing the 
bacteria.  It is estimated that fewer than ten bacteria are necessary to establish infection, far less 
than most other pathogens.  The smallest droplets containing bacteria settle into the distal airway, 
where alveolar macrophages, the sentinels of the lung responsible for clearing inhaled particles 
and disposing of encountered microorganisms phagocytose Mtb.  It is not known how often the 
initial interaction between host macrophage and Mtb results in productive infection, however 
Mtb is exquistaly adapted to overtake alveolar macrophages.  The infected macrophage sounds 
the alarm of its infection by releasing pro-inflammatory cytokines, such as IL-12.  Most often the 
infected alveolar macrophage undergoes necrosis, an inflammatory form of cell death that further 
excites immune cells to the site of infection.  Neutrophils are some of the first respondants, as are 
monocyte-derived macrophages and dendritic cells.  Dendritic cells (DCs), after having taken up 
Mtb or material containing Mtb-derived antigens, traffic to the lung-draining lymph nodes to 
prime CD4+ and CD8+ T cells.  However, this process takes days, during which time the 
bacteria grow nearly unchecked
6.  When T cells finally arrive, they secrete a variety of Th1-type 
activating cytokines in an effort to activate antibacterial effector functions within macrophages, 
induce death and limit the spread of infection.      During the immune response to tuberculosis, 4 
 
the body attempts to ‘wall off’ the infection behind a granuloma- a mass of fibrous tissue and 
immune and non-immune cells.  The classic structure of the granuloma in humans consists of a 
ring of B and T cells surrounding an core of myeloid-derived cells and bacteria
7.    The 
granuloma is a sign of a proper immune response to the bacteria, however it is not without 
consequences.  The granuloma disrupts normal lung function and can spread into and erode into 
blood vessels and the airway.  When the patient coughs, Mtb can then access the airway and be 
expelled.  The granuloma is a structure advantageous to both the bacterium and the host- crucial 
for both containment and continuation of disease
8. 
Most people who encounter the bacteria never display clinical symptoms and are called 
latently infected.  In these individuals an immune response mounted against the bacteria was 
sufficient to quell the infection.  Mtb are still present and replicating within the lungs of these 
people, however they show no overt clinical symptoms of disease
9, 10.  Bacterial growth is likely 
countered by bacterial killing in these instances.  These people have a 5-10% lifetime risk of Mtb 
recrudescence, in which bacterial replication is no longer suppressed and granulomas grow and 
spread.   HIV co-infection adds a 10% yearly risk of TB recrudescence
10.  Latent TB infection, 
while not a drain on the healthcare infrastructure represents a tremendous pool of individuals 
capable of falling ill.  Latently infected individuals can be distinguished from Mtb-naïve 
individuals based on a positive tuberculin skin test reaction or one of the newly developed IFNγ 
release assays
11.   
The most widely used vaccine in the world is the tuberculosis vaccine, BCG.  BCG, or 
Bacillus Calmette-Guérin was developed by two French doctors at the Pasteur Institute from 
1906-1919 by subculturing Mycobacterium bovis until it had lost much of its virulence.  BCG is 
thus an attenuated strain of M. bovis, harboring many, but not all of Mtb’s antigens.  Most 5 
 
notably, BCG lacks the region of difference 1 (RD1) that encompasses ESX-1, a secretion 
system required for the export of several crucial virulence factors and immunodominant T cell 
antigens
12-14.  BCG’s efficacy is largely debated as studies have shown anywhere from 0-80% 
protection from pulmonary tuberculosis for vaccinated adults
15.  Boosting strategies have also 
failed to confer additional immunity
16.  BCG administration to newborns is still recommended, 
except in HIV
+ neonates, as the vaccine protects young children from disseminated tuberculosis 
disease
17.  However, as BCG cannot protect adults, especially in high endemic regions, the 
spread of disease continues.   Thus development of novel prophylactic strategies and treatments 
are paramount.  To most effectively counter this pathogen a more complete understanding of the 
immune response to tuberculosis is required.   
Immunity to Tuberculosis 
Mycobacterium tuberculosis is one of many bacteria from the genus of mycobacteria 
capable of infecting humans.  Other members of the family include M. leprae (leprosy) and M. 
ulcerans (Buruli ulcer) as well as several environmental mycobacteria, some of which are 
capable of infecting humans, most especially immune-compromised individuals.  M. bovis 
especially can infect humans and represents a major pathogen amongst livestock and wildlife.  
There are several other mycobacteria that infect animals, however tuberculosis exclusively 
infects humans and is only capable of human-to-human spread.  A common characteristic of all 
mycobacteria, and how they received their name, is their complex waxy outer membrane 
comprised of mycolic acid.  It is this lipidic layer that protects the bacterium from drugs and 
components of the immune system.  6 
 
  Many animal models have been developed to probe the interactions between Mtb and the 
immune system.  Monkey, guinea pig and zebrafish models have all provided substantial 
contributions to the field of tuberculosis immunology, but none more so than the mouse.  The 
availability of inbred strains, an array of genetic tools and not least of all, their small size and 
relatively low cost of maintenance have all contributed to the mouse as the primary model 
organism to the TB researcher.  Knockout mice studies have highlighted many of the important 
components of the innate and adaptive immune response to TB.  CD4
+ T cells are most 
important, but so too are CD8
+ T cells.  Th1 cytokines such as IL12 and IFNγ are required, as 
well as downstream effectors, like iNOS
18-21.  MyD88 is uniquely required not just for its role in 
TLR recognition and signaling, but downstream of the IL1 receptor as well
22, 23.  Genetic 
differences between inbred mouse strains, with some displaying greater susceptibility or 
resistance have highlighted additional genes contributing to survival
24-26.  While mouse studies 
have proven instrumental to the study of tuberculosis, there are significant caveats.  Mice do not 
develop granulomas as human patients do.  As tuberculosis is primarily a disease of rampant 
immunopathology, this is a significant difference.  The mouse granuloma generally lacks the 
caseating necrotic or hypoxic center characteristic of many human granulomas
27.  This is due to 
genetic differences between mouse and man, loci have been found in immunocometent mice that 
once deleted result in granulomas bearing greater resemblance to human caseous granulomas
24.  
Vitamin D in humans contributes the production of antibacterial peptides, which are capable of 
killing Mtb
28.  In fact it is speculated that exposure and subsequent Vitamin D production that 
lead to the successful outcomes of many sanatorium patients in the 1800s.  In fact, vitamin D 
deficiency is linked with disease recrudescence
29.   Mice also lack granulysin, a protein found in 
cytotoxic granules, which human CD8
+ T cells use to directly kill Mtb
30.  There are other 7 
 
numerous differences, however many findings using mouse studies, both in vivo and in vitro 
have recapitulated human data.  
  The study of humans with primary immunodeficiencies, inborn errors of the immune 
system, with Mendelian susceptibility to mycobacterial diseases (MSMD), including 
environmental mycobacterial infections and extreme sensitivity to BCG, further confirmed the 
mouse data.  Patients lacking functional components of the IL-12/IFNγ signaling axis struggle 
with recurrent mycobacterial diseases their entire lives
31.  Other phagocyte-specific genes have 
been found to play a role in the immune response to Mtb.  Mutations in the macrophage/dendritic 
cell NADPH oxidase and some cathepsins both predispose patients to tuberculosis, highlighting 
the importance of phagocyte-mediated bacterial killing in control of disease
32, 33.   The anti-
rheumatoid arthritis treatments targeting TNF significantly increase patient’s risk for TB 
recrudescence, highlighting the importance of this molecule in defense
34, 35.  As tools develop 
further, more and more Mtb research will be done using human tissues, which ultimately is 
required to understand the nuances of the interactions between the bacterium and the host 
Mycobacterium tuberculosis infection of the macrophage 
  Upon inhalation, Mtb most likely first encounters the alveolar macrophage, as alveolar 
macrophages are required to establish productive Mtb infection
36.  Macrophages use many 
receptors to mediate recognition and phagocytosis of Mtb
37.  While alveolar macrophages are 
potent killers, capable of phagocytosing and destroying most pathogens and particles 
encountered, Mtb is different, and persists within an arrested phagosome.  Lysosomes typically 
rapidly fuse with the nascent phagosome, delivering their caustic cargo responsible for digesting 
the internalized object.  A series of GTPases facilitate the recruitment, tethering and fusion of 8 
 
lysosomes to the phagosome.  Rab5 decorates the early phagosome and is present on Mtb-
containing phagosomes
38.  Typically Rab5 gives way to Rab7 in what is called ‘Rab conversion’, 
which facilitates fusion to lysosomes via the Rab7 effector RILP
39, 40.  Most studies have found 
the Mtb excludes Rab7 from its phagosome.  This is thought to happen by retaining Rab22a, 
which required for the Rab5 to Rab7 conversion
41.   Many Rab proteins clearly facilitate 
phagosomal maturation of non-pathogenic bacteria and particles and many of these are disrupted 
following Mtb infection, however the exact nature of these interactions are not entirely 
understood
42.  Over expression of Rab10 rescues the phagolysosome maturation arrest, 
demonstrating that multiple host GTPases may be targeted by the bacterium to ensure it remains 
safe within the phagosome
43.  The end result of Rab disruption is the incomplete fusion of the 
Mtb phagosome with lysosomes and other vesicles responsible for degrading phagosomal 
contents.  One Rab5 effector, EEA1 is required for endosome trafficking and the delivery of 
proteolytically inactive cathepsins, however Mtb interferes with EEA1 recruitment.  The extent 
to which the Mtb phagosome takes on lysosomal characteristics is also under debate.  Some find 
nearly complete exclusion of lysosomal proteins, such as LAMP1 from the Mtb phagosome, 
while others find some co-localization of Mtb with lysosomal markers
44.   
While there is debate over the exact composition of the Mtb phagosome, there is 
consensus regarding the block of acidification of the Mtb phagosome.  Mtb phagosomes 
specifically lack vATPase, capable of turning the phagosome into an acidic environment and 
activating the many lipases and proteases delivered by endosomes and lysosomes
45.  As such, the 
Mtb phagosome remains nearly neutral, estimated at a pH of 6.4 which is hospitable for the 
bacteria
46.  While Mtb halts phagolysosome fusion, recycling is not completely inhibited.  
Vesicles containing transferrin and transferrin receptor readily dock with the Mtb-phagosome, 9 
 
delivering nutrients such as iron to sustain bacterial growth
47.  Thus Mtb can proliferate within 
an immature phagosome
48.  Activating cytokines, such as IFNγ can overcome this maturation 
block and is a major mechanism of Mtb killing both in vitro and in vivo
49.  IFNγ binding to its 
receptor upregulates an estimated 1000 genes of which only a handful are known to participate in 
immunity to tuberculosis.  Yet, IFNγ represents one of the most crucial tools the immune system 
possesses to fight Mtb infection.  Most notably, IFNγ upregulates the inducible nitric oxide 
synthase (iNOS), which is responsible for the production of reactive oxygen species capable of 
damaging the bacterium.    Mtb modulates the host macrophages’ response to IFNγ, thus further 
protecting itself from the macrophage’s bactericidal activities, including preventing iNOS 
recruitment to the Mtb-containing phagosome
50, 51.   
Mtb infection has other effects on the macrophage.  Major Histocompatibility Complex 
(MHC) class II expression on the surface of Mtb infected macrophages is markedly decreased
52.  
As MHC complexed to antigen is required for T cells to recognize Mtb-infected macrophages 
this is an important strategy Mtb employs to avoid detection.  MHC class II antigen processing 
and surface presentation is upregulated in response to IFNγ.  As Mtb limits the macrophages’ 
responsiveness to IFNγ, this is yet another mechanism the bacteria use to evade immune 
surveillance
53.  Additionally, bacterial lipoproteins bind to Toll-Like Receptors (TLRs) and 
cause prolonged downregulation  of MHC expression
54.  Ultimately this has the effect of hiding 
the bacteria from the adaptive immune response.   
Death of the Mycobacterium tuberculosis-infected macrophage 
  At some point during intracellular infection, the Mtb-infected macrophage dies.  Infection 
with virulent Mtb most often results in necrosis, while avirulent Mtb mutants and strains cause 10 
 
more apoptosis
55, 56.  However, it is important to note that the cell death pathways are highly 
nuanced, and both apoptosis and necrosis are observed following virulent Mtb infection.  As a 
common response to intracellular infection is cell death, it is not clear whether the death program 
is initiated by the macrophage, or by the bacteria, but it is clear that Mtb influences and alters 
macrophage cell death to its advantage.  Necrosis releases free bacteria, which can infect 
surrounding macrophages and is a mechanism to spread infection and evade immunity
57.  
Apoptosis however confines the bacterium within an apoptotic bleb or cell and is correlated with 
control of the bacterium and establishment of a robust protective adaptive immune response
58, 59.  
Other forms of cell death, including caspase-independent apoptosis and pyroptosis, have been 
reported following Mtb infection, however is it unclear how great a role they play in vivo, in 
regards to bacterial control, adaptive immune priming and pathology
60-63.  And while the 
signaling cascades involved in these forms of cell death are very different from apoptosis and 
necrosis, morphologically they closely resemble apoptosis or necrosis, and thus might have 
similar impacts on bacterial growth and immunity. 
  Apoptosis and necrosis were first described based on morphological changes in cells 
observed in tissue culture by light microscopy.  Apoptosis, or programmed cell death, is a highly 
coordinated energy-intensive process that packages cellular components into blebs, condenses 
chromatin and protects the plasma membrane from disintegration
64.   While there are many 
triggers for apoptosis, classically they all filter into one of two caspase cascades: the extrinsic 
caspase-8 dominant cascade and the intrinsic caspase-9 dominant cascade.  Cell extrinsic stimuli, 
require the ligation and dimerization of surface receptors comprised of death domains, such as 
TNF and Fas to  stimulate apoptosis via the caspase 8-dependent extrinsic pathway
65.  As TNF 
and Fas-mediated phagocyte killing occur during Mtb infection, the extrinsic apoptosis pathway 11 
 
likely occurs in vivo.  Stimuli originating from the cell itself, such as microbial danger signals, 
DNA damage and ER stress trigger caspase 9-dependent intrinsic pathway, relying on 
mitochondrial outer membrane permeability and release of cytochrome c
66.  Caspase 8 activation 
in some cases will also lead to BID cleavage and cytochrome c release
67.  Both pathways feed 
into caspase 3 activation, which helps coordinate and activate intracellular proteases responsible 
for dismantling the cytoskeleton and partitioning organelles into blebs
68.  Fundamentally, 
apoptosis maintains the integrity of the plasma membrane
69.  Necrosis however, does not.  
Previously it was thought that necrosis was an uncoordinated event in which a cell explodes or 
disintegrates, losing plasma membrane structure and leakage of intracellular contents.  Now, 
some forms and situations of necrosis appear to be as regulated as apoptosis, and may have 
important immunological function
70.  However it is not known whether this is the case following 
Mtb infection. 
  It is not clear what bacterial effector molecules, if any, interact with the host macrophage 
to induce cell death.  Some reports have implicated ESAT-6, a member of the virulence 
apparatus, ESX-1,  in triggering cell death
71.  Alternatively, PE_PGRS33 was found recruited to 
mitochondria as a prerequisite for cell death
72.  However, these reports remain unsubstantiated.  
There are bacterial proteins that influence the type of death experienced by the macrophage, but 
whether or not they specifically start the death cascade or merely influence it while it is started is 
unknown.  Bacterial superoxide dismutase, SodA, inhibits apoptosis
73.  Mutants lacking NuoG, a 
NADPH dehydrogenase also induce less necrosis and more apoptosis in infected macrophages
56.  
Additionally, it is unknown whether or not bacteria are within the phagosome or have escaped 
into the cytosol at the onset of apoptosis or necrosis.  As a loss of organelle membrane integrity 
is common at the onset of necrosis, determining the subcellular localization of Mtb during or 12 
 
right before cell death is difficult.  An important consideration during apoptosis is the 
maintenance of the plasma membrane.  During apoptosis flipases are activated to facilitate the 
movement of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma 
membrane.  Annexins are simultaneously translocated from the cytosol to the exofacial leaflet of 
the plasma membrane, although the mechanism is unknown
74.  Annexin I binds PS and then 
transglutaminase crosslinks the N-terminal tails of annexin I, forming a dense meshwork
75.  This 
is referred to as the apoptotic envelope and serves to stabilize the dying cell and may facilitate 
bleb formation
76.  Virulent Mtb infection perturbs apoptotic envelope formation by inhibiting 
plasminogen activator inhibitor type 2 (PAI2), an enzyme that protects annexin I from 
proteolysis, dismantling the apoptotic envelope
77.  This promotes necrosis.  Another way to 
stabilize the plasma membrane during apoptosis is via plasma membrane repair.  The continual 
recruitment of lysosome and Golgi-derived membrane to the plasma membrane helps heal and 
maintain the dying cell.  Virulent Mtb infection also interferes with this process.  Mtb infection 
alters the production of many immunologically potent eicosanoids, chief among them lipoxin A4 
and prostaglandin E2
78.  PGE2 signaling via its EP4 receptor aids in synaptotagmin-7 mediated 
lysosomal plasma membrane repair
79.  LXA4 antagonizes this.  As PGE2 is inhibited following 
virulent Mtb infection, but not avirulent, this is yet another mechanism that pushes the dying 
macrophage towards a necrotic rather than apoptotic death.    
  Mitochondrial stability is a major regulator of cell death.  Mitochondrial outer membrane 
permeability (MOMP) is a hallmark of intrinsic apoptosis as BID cleavage activates the 
BAX/BAK pore responsible for the release of cytochrome c and other pro-apoptotic molecules
80.  
If the inner mitochondrial membrane is perturbed simultaneously with MOMP the mitochondria 
loses proton potential, resulting in necrosis
81.  Virulent Mtb infection causes necrosis through 13 
 
this mechanism, although it is unclear how the bacteria might target the mitochondria
82.  PGE2 
signaling through the EP2 receptor protects the mitochondrial membrane from damage and 
necrosis
78.   
  Just as necrosis has been found to benefit the bacteria and further the infection, apoptosis 
is beneficial for the host and restricts bacterial replication.   There are many examples of 
apoptosis correlating with decreased bacterial load.  First, less virulent forms of Mtb and closely 
related mycobacteria induce apoptosis and grow poorly in macrophage culture
82, 83.  Some of the 
bacterial mutants discussed above, SodA, NuoG and SecA2 all induce apoptosis and 
consequently do not proliferate in vitro or in vivo
58, 73, 84.  Even using virulent bacteria, apoptotic 
death was associated with reduced bacterial burden
85.  Treatment of BCG-infected macrophages 
with FasL induced apoptosis as well as a decline in bacterial burden
86.  Chemically inducing 
apoptosis in Mtb-infected human monocyte-derived macrophages similarly lead to decreased 
bacterial burden
87.  Apoptosis of S. pneumonia-infected cells is also associated with reduced 
bacterial viability, suggesting apoptosis as a general mechanism of antibacterial host defense
88, 
89. 
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Figure 1-1. Receptors and ligands for apoptotic cell recognition and engulfment. 
Many redundant receptors are used by phagocytes to mediated efferocytosis.  Some receptors are 
cell and tissue-specific.  Phosphatidylserine (PS) displayed on the surface of the dying cell is the 
major ligand that directly or indirectly binds to several efferocytosis receptors.  This image 
depicts most of the known receptors and ligands.   
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Efferocytosis:  Apoptotic Cell Clearance 
  There is constant cell turnover in the body.  During development structures form, only to 
be destroyed, such as the webbing between digits
90.  The end-stage of the immune response to 
pathogens involves the removal of many of the recruited cells.  Clearance of germ cells in the 
male gonad is required for spermatogenesis
91.  An estimated 10
9 cells apoptose in the human 
body daily, and they all must be cleared to prevent spillage of their phlogistic cargo
92.   This 
crucial cell clearance function is the duty of phagocytic cells- mainly macrophages.  The 
engulfment and clearance of apoptotic cells is called efferocytosis, from the Greek ‘to take to the 
grave’.   During apoptosis dying cells release ‘find me’ signals, such as ATP, UTP, and peptides 
derived from Annexin proteins to attract nearby phagocytes
93-95.  Dying cells also display on 
their surface a variety of ‘eat me’ signals, such as PS for which phagocytes have corresponding 
receptors to mediate the recognition, tethering and engulfment of the apoptotic cell
96.  Most 
macrophages employ a variety of redundant receptors to facilitate efferocytosis, as inhibition of 
any one does not dramatically affect the rate or number of internalized apoptotic cells.  Many 
efferocytic receptors have been identified (Figure 1-1).  Some, such as TIM4, directly bind PS on 
the surface of the dying cell
97.  Still others, such as the αvβ3 or αvβ5 integrins bind MFG-E8, a 
soluble bridge protein linking the dying cell to the phagocyte
98.  Both the complement system 
and Fc receptors can participate in apoptotic cell engulfment.  IgM pentamers have been reported 
to bind apoptotic cells by recognizing unknown epitopes.  Furthermore, C1q can bind this 
structure to mediate complement recognition of the apoptotic cell
99.  However, data so far 
suggests that both Fc receptors and the complement system appear to play a minimal role in 
efferocytosis both in vitro and in vivo
100.   16 
 
While in many ways similar to phagocytosis, efferocytosis employs distinct signaling 
cascades.  For one, efferocytosis most closely mimics macropinocytosis, as the large apoptotic 
cell is engulfed along with extracellular fluid
101, 102.  This results in a characteristic spacious 
phagosome
103.  Phagocytosis, however involves tight contact between the particle and plasma 
membrane during engulfment and the resulting phagosome snuggly fits around the internalized 
target.  The difference in the ‘efferocytic gulp’ may come from the GTPases that orchestrate 
efferocytosis.   Downstream of several efferocytosis receptors and Fc-receptor, Rac1 and Cdc42 
orchestrate the actin cytoskeleton to engulf the apoptotic cell
104, 105.  However, statins which 
enhance efferocytosis have been found to suppress Fc receptor-mediated phagocytosis, 
suggesting that there is alternative regulation of these two engulfment pathways beyond the 
involvement of Rac1 and Cdc42
106.  Perhaps this is due to differential activation of RhoA, a 
GTPase known to antagonize Rac1-mediated efferocytosis
105, 107.  After internalization, the 
efferocytic phagosome containing the dead cell matures much like phagosomes, although there is 
increasing evidence for efferocytosis-specific proteins facilitating Rab conversion on the 
efferocytic phagosome
108.  Ultimately, the internalized apoptotic cell is destroyed.  Another 
striking difference between phagocytosis and efferocytosis is the effect that dying cells have over 
macrophages.  The ingestion of dying cells promotes an anti-inflammatory program within the 
macrophage
109-111.  As macrophages engulf apoptotic cells PPARδ is upregulated and acts as a 
transcriptional sensor for apoptotic cells
112.  PPARδ then orchestrates the dampening of pro-
inflammatory cytokine generation as pro-resolving cytokine production takes over
92, 113.  
Specifically, TNF, IL-12 and IL-1β production are down-regulated as TGFβ and PGE2 are 
produced
114.   These cytokines work in an autocrine manner to inhibit or enforce efferocytosis, 
respectively.  As such, inflammation, specifically driven by TNF inhibits efferocytosis
115.  This 17 
 
has disastrous consequences during many disease states and contributes to the continuance of 
inflammation
116.  An apoptotic cell that is not cleared will fall apart in a process known as 
secondary necrosis
117.  Efferocytosis might be the primary role of the macrophage, especially 
tissue macrophages who roam the body far from openings to the outside. 
  Necrotic cells are also engulfed by phagocytes.  It is unclear whether the same receptors 
are involved in the recognition and engulfment of these cells
118.  Early necrotic cells, or cells 
dying by caspase-independent means, may be engulfed via similar methods as apoptotic cells
119.   
Some studies suggest that the uptake of necrotic cells results in an anti-inflammatory program 
similar to the efferocytosis of apoptotic cells
119, 120.  Others have found that necrotic cell cleanup 
is not immunologically silent and may form the basis of autoimmunity
121-123.  Furthermore, 
pyroptosis, caspase –dependent cell death, in many ways is morphologically similar to necrosis 
and is described as pro-inflammatory cell death as IL1 is released during or immediately 
preceding death
124.  How efferocytosis functions in response to these types of dying cells is not 
completely understood  Further study into the consequences of necrotic, pyroptotic and atypical 
cell death clearance is worthy of study.    
Efferocytosis initiates immunity 
  Another aspect of efferocytosis involves the acquisition of antigen.  Dendritic cells (DCs) 
are a large population of highly phagocytic cells, constantly engulfing and sampling the 
periphery in search of microbes.  One way that DC can acquire antigens from intracellular 
bacteria or viruses to prime protective T cells is to uptake apoptotic blebs from infected cells
125.  
Similarly, Yrlid et al. found that virulent Salmonella, an intracellular bacterial pathogen, induces 
apoptosis of infected macrophages and that DC are able to cross-present the bacterial antigens 18 
 
onto MHC class I molecules
126.  Cross presentation of antigens derived from efferocytosed 
apoptotic blebs by DCs can prime and alert protective CD8
+ T cells.  Apoptosis of Mtb-infected 
macrophages and the subsequent uptake of these blebs confer protective immunity.  Winau et al. 
used vesicles purified from BCG infected macrophages to immunize mice
127.  The purified 
apoptotic blebs contained bacterial antigens, but no bacteria.  CD8
+ T cell priming was observed 
and required an intact class I MHC pathway.  This strategy generated immunity that protected 
mice from challenge with virulent Mtb.  Transfer of Mtb-infected 5LO
-/- pro-apoptotic 
macrophages into mice also generated a robust CD8
+ as well as CD4
+ T cell response much more 
rapidly than the transfer of wildtype infected macrophages
59.  Thus, the efferocytosis of 
apoptotic cells containing antigens by DCs aids in the establishment of protective immunity. 
Efferocytosis and infection 
  Cell death is a feature of many intracellular infections.  Bacteria and viruses modulate the 
cell death pathways of their host cells to their advantage.  Apoptosis is a general mechanism of 
host resistance that many pathogens try to avoid
128.  For instance, Shigella induces necrosis to 
aid its escape from the host cytosol
129.  Streptococcus pneumonia infected macrophages that die 
by apoptosis limit bacterial replication
130.  The induction of apoptosis by cytotoxic CD8
+ T cells 
contributes to immunity to influenza.  In fact, killing a flu-infected cell eliminates the virus, 
suggesting that apoptosis itself is virucidal
131.  However, it was later found that viral replication 
was only inhibited following apoptosis when phagocytic cells were present to engulf the dying 
infected cells
132, 133.  This was the first evidence that efferocytosis of an infected cell can lead to 
pathogen destruction.  However, there also exists evidence that efferocytosis of an infected cell 
contributes to pathogen survival and the establishment of infection. 19 
 
Leishmania enter their host via the bite of an infected sandfly.  Neutrophils rapidly 
respond to the site of injury and phagocytose the parasite.  The infected neutrophils subsequently 
die and are efferocytosed by responding macrophages, allowing the parasite to establish a 
productive infection
134, 135.  This is known as the ‘Trojan Horse’ model of Leishmania infection.  
However intact, infected neutrophils were not found within macrophages in vivo
134.  Thus, it is 
not certain whether the dying neutrophils are apoptotic, or release the parasite as they die to be 
subsequently engulfed by macrophages.  Chlamydia similarly infects neutrophils with an aim to 
ultimately enter macrophages through efferocytosis
136.  Phagocytes within the zebrafish embryo 
were observed taking up material from M. marinum dying cells and this contributed to spreading 
the infection, however it was unclear whether or not dying cells were necrotic or apoptotic
137.  
These few instances are the only reports of the efferocytosis of infected cells.  In each of these 
reports efferocytosis was observed and it seemed to correlate with pathogen survival, but 
efferocytosis was no systematically studied.  Some investigators have studied the impact of 
infection on efferocytosis.  Infection with Fransicella novicidia impairs macrophage 
efferocytosis and skews the macrophages towards an ‘alternatively activated’ M2 phenotype
138.  
Conversely, efferocytosis of apoptotic cells was found to inhibit alveolar macrophages’ ability to 
kill Streptococcus pneumonia
139.   A DC engulfing an apoptotic cell and receiving TLR stimulus 
simultaneously initiates a Th17 response, most suitable for clearance of extracellular bacteria
140, 
141.    Given the host-protective role of apoptosis during Mtb infection and the lack of data 
surrounding apoptosis as directly bactericidal, we were interested in investigating the role of 
efferocytosis during Mtb infection. 
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Scope of the Thesis 
In this thesis I present efferocytosis, the process of apoptotic cell engulfment as a novel 
innate immune antibacterial mechanism.  First, in Chapter 2 I show that there is a significant 
amount of apoptosis following virulent Mtb infection of macrophages, despite evidence that Mtb 
favors necrosis (Chapter 2).  Following apoptosis, we find Mtb-infected apoptotic cells are taken 
up by uninfected macrophages by efferocytosis, using both newly developed in vitro and in vivo 
models (Chapter 2).  In Chapter 3 I show that conditions that allow for efferocytosis are 
associated with decreased bacterial growth in vitro.  This growth suppression is in fact mediated 
by efferocytosis.  Finally, Chapter 4 demonstrates that the efferocytic phagosome containing Mtb 
is a unique structure capable of fusing with lysosomes.  This process of efferocytic phagosome 
maturation is bactericidal.  Thus in this work we present efferocytosis as a novel bactrericidal 
mechanism, capable of killing Mtb. 
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Abstract 
A variety of intracellular pathogens modulate host cell death pathways as part of their virulence 
strategies.  Mycobacterium tuberculosis infection typically ends in the necrotic death of the 
macrophage it infects to aid its dissemination and evasion of immunity.  However the spectrum 
of cell death is highly nuanced, with infection leading to both apoptosis and necrosis.  In vivo, 
dying cells are rarely observed as they are quickly engulfed through the process of efferocytosis.  
We report here that Mycobacterium tuberculosis-infected macrophages die via caspase-
dependent apoptosis and are subsequently engulfed by bystander uninfected macrophages.  This 
process of infected macrophage efferocytosis is observed using a variety of macrophage types 
both in vitro and in vivo.  Mycobacterium tuberculosis infection did not specifically inhibit 
efferocytosis and as such efferocytosis may play an important role in vivo during active disease. 
Introduction 
Mycobacterium tuberculosis (Mtb) evades host immunity to survive and replicate within 
macrophages.  Despite nearly a century of research, how the bacteria are able to so effectively 
dismantle the macrophages’ innate antibacterial mechanisms remains unknown.  One of the 
bacteria’s strategies to persist and cause chronic infection is to modulate the cell death pathways 
of the macrophages it infects
1.  Apoptosis has long been appreciated for its ability to control 
bacterial growth; however the mechanism for this remains unknown.  Indeed, there are many 
mutants and attenuated strains of Mtb that induce apoptosis and as such do not proliferate 
robustly in macrophage culture.  H37Ra is a lab-adapted ‘attenuated’ strain, genetically very 
similar to the lab-adapted H37Rv ‘virulent’ strain, save for a few mutations
2.  These mutations 
have rendered H37Ra less able to grow and proliferate in macrophages, and at the same time, 34 
 
induce far more apoptosis in macrophage culture than H37Rv
3,4.  Specific genes have been 
identified in Mtb that influence the infected macrophage’s fate as well.  NuoG, a NADH 
dehydrogenase, inhibits apoptosis and contributes to Mtb’s virulence
5.   NuoG counters TNF-
mediated inducible nitric oxide synthase (iNOS) activity and apoptotic cascade
6.  The SecA2 
alternative secretion apparatus is responsible for the translocation of several Mtb effectors into 
the extracellular space; chief among them is the superoxide dismutase, SodA
7,8.  Mtb mutants in 
SodA and SecA2 which is responsible for its secretion, cause more apoptosis and have limited 
virulence
8-10. There may be many other Mtb genes responsible for apoptosis suppression and 
induction of necrosis
11.  Closely related non-pathogenic mycobacterial species induce 
macrophage apoptosis as well, further highlighting the link between apoptosis and suppression of 
bacterial growth
12.  Host factors also contribute to the death modality of an Mtb-infected 
macrophage.  Prosteglandin E2 (PGE2) production during Mtb infection can protect a dying 
cell’s plasma membrane, thus preventing necrosis and skews the macrophage to a more apoptotic 
fate
13.  PGE2 also stabilizes the mitochondrial membrane to prevent the mitochondrial 
permeability transition associated with necrosis
14,15.  IFNγ-activated macrophages avoid necrotic 
cell death potentially through NO-mediated signaling
16.  In all of these examples, apoptosis is 
related to a decrease in bacterial burden and a favorable outcome for the host. 
  Apoptosis is often referred to as ‘programmed cell death’ in that it follows a highly 
organized cascade of events with the purpose of dismantling the cell while keeping its membrane 
intact so as to not release inflammatory autoantigens
17,18. Primarily, apoptosis proceeds down 
two pathways: intrinsic and extrinsic, that both converge upon the activation of caspase 3.  
Intrinsic apoptosis is in response to perturbations from within the cell- whether they be pathogen 
or stress derived.  Intrinsic apoptosis relies on the activation of caspase 9.  Extrinsic apoptosis, 35 
 
mediated by caspase 8, requires that the cell receive the signal to die from an external signal, 
most notably via engagement of the TNF receptor
19,20.  Apoptosis is an innate defense 
mechanism for bacterial control and is responsible for bacterial growth suppression in vitro, but 
it also contributes in vivo to the production of a robust T cell response.  Dendritic cells can 
present antigens derived from infected apoptotic macrophages to initiate a protective CD8+ T 
cell response
21,22.  
 Necrosis conversely allows the bacteria to escape its macrophage host and infect 
surrounding macrophages and is a major virulence strategy and source of immunopathology 
during disease.  Virulent Mtb infection induces robust leukotriene A4 (LXA4), which 
antagonizes PGE2, leading to mitochondrial instability, prevention of plasma membrane repair 
and cell death
3,13.  The end result is necrosis and prolific bacterial growth.  Additionally, LXA4 
impairs the establishment of a protective CD8
+ T cell response and leads to worse outcome in 
vivo
22.  Necrosis, unlike apoptosis, is a form of cell death that results in the disintegration of the 
plasma membrane and leakage of intracellular content.  It is now appreciated that necrosis is not 
as ‘un programmed’ as was first thought and may rely on intracellular signaling events
23.  
Apoptosis and necrosis of Mtb infected macrophages has been reported using both human and 
murine macrophages
13,24-26.  However, the relative contribution of these two forms of cell death 
during active infection or latency remains unknown.  And while necrosis is characteristic of 
virulent Mtb infection, a spectrum of cell death is observed
27.  In vitro, many apoptotic cells may 
eventually disintegrate through the process of secondary necrosis, which is phenotypically 
similar to necrosis.  Additionally, many assays used to measure cell death cannot differentiate 
secondary necrosis from necrosis.  Consequently, the majority of macrophage cell death 
following Mtb infection in vitro is mistakenly attributed to necrosis.  However in vivo apoptotic 36 
 
cells rarely undergo secondary necrosis in this manner.  Apoptotic cell clearance is so rapid 
detection of apoptotic cells in vivo is difficult.     
  As a cell dies it releases ‘find me’ and displays on its surface a variety of ‘eat me’ ligands 
to attract phagocytes.  Phagocytes, mainly macrophages, utilize these ‘eat me’ signals to mediate 
the recognition, tethering and engulfment of apoptotic cells
28,29.  The process of apoptotic cell 
engulfment is called efferocytosis and is a crucial function of macrophages involved in the 
resolution of infection and organogenesis
30.  The process of apoptotic cell engulfment has been 
studied extensively and as such many receptors and their downstream signaling components have 
been identified.  Despite a growing body of knowledge surrounding the study of dead cell 
engulfment, much remains unknown about the consequences of efferocytosis of infected cells.   
  We sought to understand the consequences of cell death following Mtb infection.  First, 
we sought to better understand virulent Mtb-induced apoptosis in wildtype macrophage.  Indeed, 
we find that a spectrum of death modalities, including apoptosis results after infection.  As 
efferocytosis is an important function of macrophages upon encounter of an apoptotic cell, we 
asked whether efferocytosis of Mtb-infected apoptotic macrophages occurs during Mtb infection.    
We found a significant amount of efferocytosis of Mtb-infected macrophages in vitro and in 
vivo.  Additionally, Mtb infection does not impair efferocytosis, indicating that this constitutive 
macrophage process may occur in vivo in the Mtb-infected lung.   
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Results 
Mtb- infected macrophages undergo apoptosis 
While virulent Mtb predominantly induces necrosis of both human and murine 
macrophages in vitro, particularly after several days or at high multiplicity of infection (MOI), 
careful analysis revealed that a spectrum of cell death modalities are observed, including 
apoptosis.  Thioglycollate-elicited CD11b
+ peritoneal macrophages were infected with mCherry-
expressing H37Rv, resulting in the majority of macrophages harboring 1-5 bacteria.  This 
bacterial burden is similar to the burden of infection observed in macrophages in the infected 
lung.  Two days after infection 15% of infected macrophages were apoptotic as determined by 
TdT-mediated d-UTP nick end labeling (TUNEL) of apoptotic macrophage nuclei (Figure 2-1A).  
Infected macrophages incubated with 10µM cell-permeable irreversible peptide inhibitors 
directed against caspase 3 and caspase 9 had markedly less apoptosis compared to untreated and 
control peptide treated macrophages (Figure 2-1B).  Caspase 8 inhibition had no effect, though in 
other systems 10µM is sufficient to block caspase 8 activity (data not shown).  Thus we can 
conclude that at this time point, apoptosis is executed primarily via the intrinsic apoptosis 
pathway.  There was not significant bystander apoptosis of uninfected macrophages within the 
infected macrophage conditions (data not shown).    
Detection of Mtb-infected apoptotic macrophages engulfed by uninfected macrophages 
Phagocytes rapidly clear dying cells in vivo; however, whether Mtb-infected apoptotic 
cells are engulfed by macrophages has never been examined.  We observed TUNEL
+ nuclei 
contained within healthy, intact macrophages, indicating that Mtb-infected apoptotic cells could 
be engulfed by other macrophages. To formally study efferocytosis of Mtb-infected macrophages 
we developed a confocal microscopy assay to monitor the fate of infected macrophages (Figure  38 
 
 
Figure 2-1.  Virulent Mtb induces apoptosis of infected macrophages.   
A.  Apoptotic CD11b
+ thioglycollate-elicited peritoneal macrophage (pMφ) infected with 
mCherry-H37Rv two days post infection.  Panels show Mtb(red), TUNEL (green), DNA (far 
red/pseudocolor blue) and merge.  Image is representative of 3 experiments.  B.  Percent 
TUNEL
+ infected pMφs of total pMφs.  Macrophages were infected with Mtb, washed and 
10µM indicated caspase inhibitors or negative control peptide (ctrl) was added before cells were 
imaged.  Red dashed line is mean apoptosis of uninfected macrophages.  Data is representative 
of 3 experiments.  Error bars ± SEM; *, p ≤ 0.05 One-way ANOVA. 
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2-2A).  An important consideration for studying the fate of an Mtb-infected is to distinguish it 
from uninfected macrophages and to detect the dead cell after it has been engulfed.  Many 
researchers study efferocytosis in non-infectious settings by fluorescently staining thymocytes 
with an intracellular dye before inducing apoptosis.  This allows internalized apoptotic cells to be 
easily detected by FACS or visualized by microscopy.  We based our assay on this standard 
approach.   
Macrophages from C57Bl/6 mice, which express the CD45.2 allele (hereafter referred to 
as CD45.2 macrophages) were labeled with DiO, a green fluorescent stain that intercalates into 
membranes and infected with mCherry-H37Rv before adding uninfected congenic CD45.1 
macrophages.  CD45.1 macrophages were added at a ratio of 2:1. Under these conditions there 
was no discernible transfer of dye between the macrophage membranes and bacterial membranes 
(data not shown).  There exist three predicted scenarios after overnight co-culture.  First, Mtb can 
remain within the first cell it infects – a primary infected cell (Figure 2-2Ai).  Second, necrosis 
of an infected macrophage allows Mtb to disperse into the culture supernatant and to infect other 
macrophages (Figure 2-2Aii). These are secondarily infected macrophages.  As the uninfected 
CD45.1 outnumber the DiO-dyed primary infected macrophages, there is a greater chance that 
the CD45.1 macrophages would take up the extracellular bacteria.  However, DiO-dyed 
macrophages could also become secondarily infected or engulf a DiO
+ Mtb
+ apoptotic 
macrophage.  These instances would be indistinguishable from primary infected macrophages.  
Thus, we seeded macrophages primary macrophages at low density, and added two times the 
number of CD45.1 macrophages.  Third, an adjacent CD45.1 macrophage could engulf an Mtb-
infected apoptotic macrophage (Figure 2-2Aiii).  This is efferocytosis.  Again, a DiO-dyed 
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Figure 2-2.  Efferocytosis of Mtb-infected macrophages in vitro 
A. Assay for detecting efferocytosis of Mtb-infected apoptotic cells in vitro by confocal 
microscopy and its three predicted outcomes.  B. Confocal microscopy images of CD45.2
+ pMφs 
dyed with DiO, infected with mCherry-H37Rv and co-cultured with uninfected undyed CD45.1
+ 
pMφs for 16 hours before fixation and visualization.  Depicted are the three predicted outcomes 
of the efferocytosis assay; primary infection (i), secondary infection (ii) and efferocytosis (iii).  
Panels show Mtb (red), DiO (green) and CD45.1 (far-red/pseudocolor blue) and merge.  Images 
are representative of ≥20 experiments. C.  Percentage of Mtb within primary infected cells 
(68%), efferocytic cells (21%) or secondary infection (11%) 1 day post infection.  Data is mean 
of 12 experiments. 
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CD45.2 macrophage could potentially engulf an infected apoptotic cell, and this would be 
undetectable.    
One day after co-culture of infected and uninfected macrophages, all three scenarios were 
observed (Figure 2-2B).  The majority of Mtb were within primary infected macrophages.  
However, 21.7±1.7% of Mtb were within efferocytic cells and 9.8±1.2% spread into secondarily 
infected cells (mean ± SEM; n=12 experiments), which closely corresponds to the amount of cell 
death observed at this time point (Figure 2-2C).  Secondarily infected cells and efferocytic cells 
are distinguished based on whether or not Mtb colocalizes within discrete DiO
+ vesicles within a 
CD45.1 macrophage.  This analysis may underestimate the frequency of efferocytosis if the DiO 
label is degraded following efferocytosis.  Although we observed loss of the DiO signal in 
primary infected macrophages after 48 hours, it was not evident at 24 hours, the time point 
chosen for these experiments.  Additionally, secondary infection might be overestimated, as not 
all extracellular Mtb can be removed, even by extensive washing.  Thus a small amount of free 
bacteria remained when the uninfected macrophages were added.   
Efferocytosis was observed using thioglycollate-elicited peritoneal macrophages, resident 
peritoneal macrophages, and bone-marrow derived macrophages (Figure 2-3C,D).  Images are 
representative of ≥ 12 experiments. Thus, this is a general feature of macrophages.    We also 
found that Mtb infection does not significantly impair macrophage engulfment of apoptotic 
thymocytes, indicating that Mtb infection does not directly inhibit efferocytosis (Figure 2-4A).  
Furthermore, we found that supernatant taken from Mtb-infected macrophage culture does not 
inhibit efferocytosis.  In this assay, uninfected macrophages were cultured with supernatant from 
Mtb-infected macrophages for 6 hours before CFSE-labeled apoptotic thymocytes were added.  
The supernatant from infected macrophages had no effect on uptake of apoptotic thymocytes by  42 
 
 
Figure 2-3.  Many macrophage types can engulf Mtb-infected apoptotic macrophages 
A.  Efferocytosis seen using the above assay described in Figure 2-2 performed with resident 
peritoneal macrophages (rMφs).  B. Efferocytosis assay performed with M-CSF matured bone 
marrow-derived macrophages (BMDMφs).  Mtb(red), DiO(green), CD45.1(far red/pseudocolor 
blue), and merge.   Images are representative of ≥ 12 experiments. 
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uninfected macrophages (Figure 2-4B).  As a control, phagocytosis of heat-killed Alexa 488 
conjugated Escherichia coli was also unaffected.  Thus Mtb infection does not specifically 
inhibit efferocytosis at these timepoints in vitro.    
Modulation of apoptosis alters efferocytosis 
Next, we sought to confirm that our assay was reliably measuring efferocytosis.  As 
apoptosis naturally precedes efferocytosis, we sought to modulate apoptosis and measure it’s 
effects on efferocytosis.  5LO
-/- macrophages cannot produce LXA4 and thus PGE2 production 
following Mtb infection is disinhibited following Mtb infection.  These macrophages are more 
likely to undergo apoptosis than wildtype macrophages (Figure 2-5A).  PGES
-/- macrophages 
cannot produce PGE2 following infection, and thus are more prone to a necrotic death after Mtb 
infection.  We infected DiO-dyed 5LO
-/- macrophages with mCherry-H37Rv before addition of 
uninfected CD45.1 macrophages.  We then measured efferocytosis by microscopy.  Significantly 
more efferocytosis was found following 5LO
-/- macrophage infection than wildtype and the pro-
necrotic PGES
-/- macrophage (Figure 2-5B).   To further confirm that we have observed 
efferocytosis of Mtb-infected apoptotic macrophages we sought to inhibit apoptosis in wildtype 
macrophages.   As we have found that caspases 3 and 9 are required for apoptosis of Mtb-
infected macrophages early in in vitro infection, we inhibited those caspases and measured 
efferocytosis by microscopy.  Just as caspase inhibition decreased the incidence of apoptosis, 
they abrogated efferocytosis (Figure 2-5C).  Thus, we confirmed that our assay system can be 
used to monitor the fate of an Mtb-infected macrophage as it dies and is engulfed by a 
neighboring macrophage.   
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Figure 2-4.  Mtb infection does not inhibit efferocytosis 
A.   Mtb-infected macrophages can efferocytose apoptotic targets.  Uninfected macrophages or 
Mtb-infected macrophages 1 day post infection were cultured with CFSE-labeled apoptotic 
thymocytes for 1 hour prior to fixation and visualization by FACS.  Data is representative of 3 
experiments.  B.  Supernatant from Mtb-infected macrophages does not inhibit efferocytosis.  
Supernatant from 4 day Mtb-infected culture or 4 day uninfected macrophage culture was added 
to freshly isolated macrophages.  Macrophages were then cultured with CFSE-labeled apoptotic 
thymocytes or heat-killed Alexa488 E. coli for 1 hour prior to fixation and visualization by 
FACS.  Data is representative of 2 experiments. 45 
 
 
Figure 2-5. Modulation of apoptotic pathways affects efferocytosis 
A.  % TUNEL
+ Mtb-infected macrophages of total Mtb-infected macrophages from indicated 
genotypes.  Data is representative of 3 experiments.  B.  Percent efferocytosed Mtb of total Mtb 1 
day post infection of thioglycollate-elicited peritoneal macrophages (pMφs) from indicated 
genotypes co-cultured with WT uninfected macrophages.  Data representative of two 
experiments.  C.  Intrinsic pathway apoptosis inhibition restricts efferocytosis.  Macrophages 
infected with Mtb in the presence of 10µM caspase inhibitors for 1 day before fixation and 
examination by confocal microscopy as described in figure 2.  Data is representative of 3 
experiments.  Error bars ± SEM; *, p≤0.05; **, p≤0.005.  One-way ANOVA. 
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Efferocytosis occurs in vivo 
As we have found efferocytosis of Mtb-infected apoptotic macrophages in vitro, we 
sought to confirm that efferocytosis as such could happen in vivo.  Efferocytosis has only been 
studied in a limited way in vivo, due to the multiple redundant mechanisms of dead cell 
clearance.  Thus studying the relative contribution of cell types and specific receptors is limited 
in vivo.  One model for the study of efferocytosis in vivo is through intraperitoneal transfer of 
apoptotic target cells.  In this model thioglycollate was used to recruit macrophages to the 
peritoneal cavity of CD45.1 mice.  CD45.2 DiO-dyed Mtb infected macrophages were 
transferred intraperitoneally into CD45.1 mice 4 days following thiogylcollate priming.  As a 
control, uninfected macrophages were transferred into separate recipients.  The peritoneal 
cavities were lavaged 16 hours later and the retrieved cells were fixed and stained with 
antibodies directed against CD45.1 to distinguish the transferred cells from the recipients.  Cells 
were cytospun onto slides and inspected by confocal microscopy (Figure 2-6A).  Just as 
predicted, the three potential outcomes were found: Mtb within primary infected transferred 
macrophages, secondarily infected recipient macrophages and efferocytosis of transferred 
macrophage by recipient macrophages (Figure 2-6B).  Thus, efferocytosis of Mtb infected 
macrophages can occur in vivo.  
As the lung is the primary site of Mtb infection, we sought to recapitulate the 
intraperitoneal model of efferocytosis in the lung.   DiO-dyed Mtb infected macrophages were 
transferred intratracheally into the lungs of CD45.1 recipient mice.  16 hours later the lungs were 
lavaged and the retrieved cells were subject to the same fixation and staining protocols as 
described in the intraperitoneal model above (Figure 2-7A).  Efferocytosis of Mtb infected 
macrophages was observed by the recipient CD45.1 macrophages as well.  As approximately 47 
 
 
Figure 2-6.  Intraperitoneal model of efferocytosis 
A. Assay scheme.  B.  Confocal microscopy images of the three predicted outcomes.  (i) Primary 
infected transferred cell, (ii) efferocytosis and (iii) secondary infection.  Panels are Mtb (red) 
DiO (green- transferred cells) and CD45.1 (far red/pseudocolor blue- recipient cells).  Images are 
representative of 3 experiments. 
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90% of cells retrieved from a naïve mouse lung are alveolar macrophages, this demonstrates that 
efferocytosis of Mtb-infected macrophages occurs in the lung by a relevant macrophage subset.  
Very early during Mtb infection, prior to the recruitment of inflammatory monocytes, neutrophils 
and dendritic cells, alveolar macrophages are the sole cell type present in the lung
31.  Thus our 
model more closely represents early Mtb infection.  Transferred cells and secondarily infected 
macrophages were observed as well (Figure 2-7B).  Thus, efferocytosis of Mtb infected 
macrophages occurs in the lung by alveolar macrophages.  This result was not altogether 
unexpected.  Dendritic cells take up apoptotic cells and blebs during Mtb infection in order to 
cross-prime a protective CD8
+ T cell response
32,33.  As dendritic cells and macrophages are both 
highly efferocytic and rely on similar mechanisms to recognize and engulf dying targets, 
efferocytosis of Mtb-infected apoptotic macrophages is thus likely to occur during infection. 
Discussion 
It is well understood that virulent Mtb employ necrotic cell death to escape the 
macrophage and disperse into surrounding macrophages.  This is a major virulence strategy of 
the bacterium.  However, what is not appreciated is that during Mtb infection a spectrum of cell 
death is observed.  In fact, we find that apoptosis and necrosis both follow virulent Mtb 
infection.  Such heterogeneity is worthy of study as it could lead to a better understanding of how 
the bacteria counters the macrophages’ innate drive towards apoptotic death.  As there is inherent 
heterogeneity on both the macrophage and bacteria side, multiple factors may be at work 
determining the ultimate fate of the infected cell.  We chose to use TUNEL as our assay for 
apoptosis as it is one of the most reliable assays for apoptosis.  TUNEL positivity is also an end 
stage marker for apoptosis and unlike other methods, TUNEL is specific for apoptosis
34.  
Previous reports have focused on necrotic cell death following Mtb infection.  It is true that there  49 
 
 
Figure 2-7 Intratracheal model of efferocytosis 
A.  Assay scheme.  B.  Confocal microscopy images of the three predicted outcomes.  (i) 
Primary infected transferred cell, (ii) efferocytosis and (iii) secondary infection.  Panels are Mtb 
(red) DiO (green- transferred cells) and CD45.1 (far red/pseudocolor blue- recipient cells).  
Images are representative of 2 experiments. 
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is significant necrosis, however we speculate that much of the necrosis detected in in vitro 
macrophage culture is the result of secondary necrosis.  Secondary necrosis results following 
apoptosis and inefficient efferocytosis.  Efferocytosis might be hampered in vitro if macrophages 
are cultured at too low density or if TNF production is robust. 
We found that two days post infection, apoptosis is largely mediated through the intrinsic 
apoptosis pathway.  As TNF production increases over time in in vitro culture as the infection 
progresses and more cells become infected, the extrinsic pathway may become more important.  
This is not to say that this is how apoptosis is executed in the lung during active disease.  TNF is 
a hallmark of the granuloma, indicating that extrinsic apoptosis probably plays a bigger role in 
the lung
35.  However, early in infection before the recruitment of T cells and monocytes, intrinsic 
pathway mediated apoptosis could play a role. 
   In vivo apoptosis is almost always followed by efferocytosis, the process of apoptotic 
cell engulfment.  Macrophages have tremendous efferocytic capacity, as they engulf 10
9 
apoptotic cells a day.  Only under some conditions are apoptotic cells not cleared by 
macrophages: most notably during rampant inflammation which suppresses the efferocytic 
machinery.  Even though efferocytosis is such a common macrophage function, the 
consequences of apoptotic cell removal during infection have been largely ignored.  As such, we 
developed assays that would allow us to track the fate of an infected cell after apoptosis.  We 
find a substantial percentage (~20%) of Mtb in in vitro culture one day post infection have been 
efferocytosed along with dead cell material by uninfected macrophages.  Efferocytosis of Mtb-
infected apoptotic cells is a general phenomenon of many macrophage types, just as efferocytosis 
has been observed and studied by many macrophage populations.   51 
 
Virulent Mtb exert a great deal of control over the macrophages they infect.  As such, we 
asked whether Mtb could inhibit efferocytosis, as this could have implications in vivo during 
active disease. We found that Mtb infected macrophages are capable of ingesting apoptotic 
thymocytes to the same extent as uninfected macrophages.  Thus, Mtb does not directly hamper 
efferocytosis.  Pro-inflammatory cytokines have been found to inhibit efferocytosis, particularly 
TNF
36.  We asked whether supernatant from Mtb-infected cultures could exert an anti-efferocytic 
effect.  However, we found no such impairment.  This does not exclude the possibility that in 
vivo or in the presence of robust TNF that Mtb-infected apoptotic cell clearance will be 
impaired.  Merely Mtb does not directly alter macrophage’s engulfment ability.  And more 
generally, phagocytosis is not altered in Mtb-infected macrophages.  Efferocytosis might be 
significantly inhibited in vivo during active disease.   
As apoptosis precedes efferocytosis, altering the amount of apoptosis should have a 
proportional effect on efferocytosis.  5LO
-/- macrophages produce PGE2 in response to virulent 
Mtb infection and as such are protected from necrosis
3.     PGES
-/- macrophages undergo more 
necrosis following infection.  Predictably, modulating apoptosis had a proportional effect on 
efferocytosis.  Inhibition of the intrinsic apoptosis likewise decreased efferocytosis, indicating 
that our assay system was reliably measuring efferocytosis.  
Moving the study of efferocytosis in vivo presented numerous challenges.  As most 
researchers who study efferocytosis do so by artificially inducing apoptosis, the biological 
questions they ask can be answered rapidly, as engulfment of apoptotic cells is rapid.  Allowing 
Mtb-infected cells to die naturally entails longer time points, which restricted analysis.  Fewer 
Mtb were found following transfer of infected cells into either the intraperitoneal space or the 
lungs as would be expected.  Images of the infected cells taken before transfer indicated that a 52 
 
high percentage of them were infected with 3+ bacteria (data not shown).  Perhaps the infected 
macrophages homed to distal sites post transfer.  Indeed, researchers who use in vivo 
efferocytosis models typically transfer apoptotic cells and lavage the cavity 1-4 hours later, 
which leaves much less time for cells to migrate out of the area.  Even so, we found efferocytosis 
of Mtb-infected macrophages by uninfected cells using two models of in vivo adoptive transfer: 
intraperitoneal and intratracheal.  Thus alveolar macrophages are capable of engulfing Mtb-
infected macrophages and may exert tremendous influence over the course of infection. 
Efferocytosis of infected cells by macrophages has been observed before.  Leishmania 
species infect neutrophils and depend on their death to enter macrophages
37,38.  During 
Leishmania infection efferocytosis is crucial for the establishment of infection.  Chlamydia 
infection similarly relies on neutrophil death to enter host macrophages by efferocytosis
39.  
Influenza, however induces apoptosis in epithelial cells only to be engulfed and killed by 
responding macrophages
40,41.  It remains to be seen how Mtb responds to efferocytosis- whether 
it is a strategy for bacterial spread or containment.  Apoptosis is known to restrict bacterial 
growth, however it is not known whether this is a direct consequence of apoptosis itself or if 
efferocytosis contributes to bacterial control.  Thus further study of efferocytosis and its potential 
impact on bacterial growth and host survival is required. 
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Methods 
Mice and macrophage isolation 
C57Bl/6 (CD45.2) and B6.SJL-Ptprc
a Pepc
b/BoyJ (CD45.1) mice were purchased from Jackson 
Laboratories (Bar Harbor USA), and were kept and bread using standard humane animal 
husbandry protocols.  Mtb-infected mice were housed under BSL3 conditions. Thioglycollate-
elicited peritoneal Mφs (pMφs) were lavaged from peritoneal cavities 4-5 days following 3% IP 
thioglycollate injection.  pMφs were isolated using CD11b microbeads and magnetic columns 
(Miltenyi Biotec) and cultured in 24 or 96 well dishes overnight prior to infection.  Resident 
peritoneal Mφs (rMφs) were lavaged from peritoneal cavities and selected based on 
CD11b
+CD19
-.  Bone marrow-derived Mφs (BMDMφs) were differentiated from bone marrow 
cells 7-10 days in RPMI supplemented with 20% L929 cell supernatant containing M-CSF.  
Alveolar Mφs (aMφs) were lavaged from the lungs of mice with PBS.   
Mtb culture and infection 
mCherry-H37Rv was cultured with 0.5ug/mL Hygromycin B.  Mtb infection was conducted as 
previously described
42 with the following modifications.  Mφs were grown in 96-well plates and 
infected at a multiplicity of infection (MOI) of 10:1 for 4 hours.  Cultures were then washed 3-5 
times.  Efferocytic Mφs were added at 2x the number of infected Mφs.  As indicated efferocytic 
Mφs were pretreated with 10µM PGE2 for 4 hours at 37
oC before washing and addition to 
infected Mφs.  Caspase inhibitors (Calbiochem) (10µM).  CFU were determined immediately 
following infection and at indicated timepoints per condition in quadruplicate by removing 
culture supernatant, lysing Mφs with 1% TritonX/PBS solution, plating serial dilutions on 7H11 
plates and incubating at 37
oC/5% CO2 for 3 weeks.  All Mtb strains were confirmed by thin layer 
chromatography to be PDIM
+.   54 
 
 
FACS efferocytosis assay 
Apoptotic thymocytes were generated by dying thymocytes with 1µM CFSE or 1µl/mL Vybrant 
DiO (Invitrogen) prior to apoptosis induction with staurosporine for 6-16 hours.  Thymocytes 
were then co-cultured with macrophages at a ratio of 5:1 for 1 hour in 24 well plate before 
washing, staining with antibodies directed against F4/80, fixation and analysis on a BD FACS 
CANTO II and FlowJo software.  Heat killed E.coli Bioparticles (Invitrogen) were added as a 
control. 
TUNEL assay for apoptosis 
Apoptosis was assessed by TUNEL (Roche) according to manufacturer’s specifications on Mφs 
grown on coverglass and fixed with 3.7% paraformaldehyde.  100 infected cells were counted 
per condition in triplicate by conventional epifluorescence microscopy using a Nikon TE2000-U 
inverted microscopy fitted with a SPOT-RT CCD camera. 
Confocal microscopy efferocytosis assay 
Mφs from CD45.2 mice were cultured in 24 well dishes in triplicate per condition upon 
coverglass and dyed with Vybrant DiO (Invitrogen) as per manufacturer’s specifications prior to 
infection with mCherry-H37Rv for 4 hours.  Uninternalized bacteria were washed away and 
uninfected CD45.1 macrophages were added at 2x the number of infected macrophages.  
Treatment conditions were added as appropriate.  16-24 hours later cells were washed and 
stained with mouse monoclonal CD45.1 (Abcam) before affixing to microscopy slides with 
Prolong Gold plus DAPI (Invitrogen Conditions were analyzed in triplicate and for each 
replicate in each condition 100-300 Mtb were counted.  Images were taken using a Nikon 
TE2000-U inverted microscopy equipped with C1 Plus confocal laser scanner. 55 
 
In vivo efferocytosis assay 
Adoptive transfer of Mtb-infected macrophages was as described previously
13.  DiO-dyed 
CD45.2 pMφs were infected in standing culture with mCherry-H37Rv for one hour.  Cells were 
washed and resuspended in PBS.  For the intraperitoneal model 5x10
6 macrophages in 1 mL 
were transferred intraperitoneally into CD45.1 mice that received 2mL 3% thioglycollate 4 days 
prior.  24 hours later the peritoneal cavity was lavaged, fixed with PFA, stained for CD45.1 as 
described above and affixed to slides by cytospin centrifugation.   For the intratracheal model 
3x105 macrophages in 100uL PBS was transferred into the lungs of uninfected CD45.1 mice via 
the intratracheal route.  24 hours later airway cells were retrieved by bronchoalveolar lavage, 
fixed with PFA, stained for CD45.1 and cytospun onto microscopy slides for confocal 
microscopy analysis. 
Image Analysis 
Microscopy images were analyzed using Image J
43 and colocalization analysis macros or user-
generated pipelines in Cell Profiler
44.  Investigators were blinded during analysis.   
Statistical Analysis 
Statistical analysis and graphical output was done with GraphPad Prism.  One-way ANOVA 
with Dunnet’s post-test.  * = p≤0.05 
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Abstract 
Mycobacterium tuberculosis (Mtb) subverts macrophage cell death pathways to ensure its 
survival and persistence.  Apoptosis of an Mtb-infected macrophage is widely recognized as a 
mechanism of bacterial control, while necrotic death promotes infection.  How precisely 
apoptosis mediates bacterial control is hitherto unknown.  We report here that apoptosis itself is 
not intrinsically bactericidal, but that it is the engulfment of Mtb-infected apoptotic cells by 
uninfected macrophages that controls the infection.  This process, known as efferocytosis thus 
emerges as a novel mechanism of bacterial control with profound implications for understanding 
the role of apoptosis in microbial infection. 
Introduction 
  Following infection of macrophages by Mycobacterium tuberculosis (Mtb) the bacilli 
persist within arrested, immature phagosomes.  Virulent Mtb inhibit macrophage apoptosis and 
ultimately induce necrosis, which enables the bacterium to evade host defenses, disperse and 
infect surrounding macrophages
1.  In contrast, attenuated Mtb strains and mutants lacking key 
virulence factors induce far less necrosis and instead stimulate apoptosis
2,3.  Apoptosis of Mtb-
infected macrophages is associated with reduced bacterial growth
4.  It is largely assumed in the 
field that apoptosis is intrinsically bactericidal; however the evidence to support this is 
incomplete. 
Molloy et al. reported decreased BCG viability in macrophages following treatment with 
ATP, which induces apoptosis
5.  Treatments that induce necrosis, such as hydrogen peroxide, 
had no effect on bacterial viability.  Thus it was concluded that apoptosis alone is bactericidal.  
Fas ligand treatment of Mtb-infected human macrophages was also found to control the 62 
 
bacteria
6.  However, in both of these studies many macrophages remained uninfected and 
unaffected by apoptosis treatment, leading us to speculate that the uninfected macrophages might 
be participating in bacterial control. 
Previous work has demonstrated that adding uninfected macrophages to infected macrophage 
culture was associated with suppression of bacterial growth.  Fratazzi and colleagues reported 
that the addition of uninfected macrophages to M. avium-infected  macrophages controlled 
bacterial growth, but only if the infected macrophages were apoptotic
7.  Co-culture with infected 
alive or necrotic macrophages had no impact on bacterial growth.  In a model of high-MOI 
induced apoptosis Lee et al found that apoptosis itself is not directly bactericidal, but that 
additional macrophages must be added to the culture to contribute to bacterial killing
8.  Addition 
of macrophages must occur shortly after infection as waiting additional days did not control 
bacterial growth, presumably because the  infected macrophages died by secondary necrosis.   
These two reports stop short of speculating or studying the mechanism of  how addition of 
uninfected macrophages  controls bacterial growth.  The assay used in these two reports to 
measure CFU control was similar to the assay we developed to study  efferocytosis of Mtb 
infected apoptotic macrophages (Chapter 2).  Thus,  we asked whether conditions in which 
efferocytosis are observed are associated with bacterial control.  Despite the substantive cell 
death that accompanies infection, the role of efferocytosis during infection, particularly with 
respect to efferocytosis of infected cells has not been investigated.  Based on the known 
association between macrophage apoptosis and host resistance to Mtb, we hypothesized that the 
antibacterial role of apoptosis is mediated by efferocytosis.   
  We previously reported in Chapter 2 that following apoptosis, infected macrophages are 
efferocytosed by uninfected macrophages.  Here we demonstrate that efferocytosis is capable of 63 
 
controlling infection.  We show that co-culture of uninfected macrophages with Mtb infected 
macrophages restricts bacterial replication in vitro in a variety of macrophage types.  We also 
report that apoptosis and then engulfment of the infected macrophage is required for bacterial 
control.  If engulfment is inhibited, secondary necrosis allows further spread of the bacteria.  
Thus, efferocytosis is a novel innate antibacterial mechanism capable of controlling of Mtb 
growth.  
Results 
Conditions that favor efferocytosis restrict Mtb growth 
Previously we reported that following Mtb infection a substantial number of the primary 
infected macrophages underwent apoptosis.  Using a microscopy assay we observed that the 
bacteria in these dying cells were engulfed along with cell debris by other macrophages.  To 
determine whether the conditions in which we observed efferocytosis affects bacterial viability, 
uninfected peritoneal macrophages were co-cultured with Mtb-infected peritoneal macrophages 
and CFU were subsequently measured.  The co-culture of uninfected thioglycollate-elicited 
peritoneal macrophages with virulent H37Rv-  or avirulent H37Ra-infected macrophages 
significantly suppressed bacterial growth for a week in culture (Figure 3-1).  The addition of 
uninfected macrophages completely suppressed  Mtb growth as the CFU through day 7 post 
infection.  The bacterial burden at day 0 was not significantly different from the CFU at day 7 in 
the macrophage co-culture condition, whereas Mtb grew robustly in primary infected 
macrophages.  Uninfected macrophages controlled Mtb growth best when they were added to 
infected macrophages at a ratio of 1.5-2 uninfected per infected macrophage.  Increasing the 
number of uninfected macrophages beyond 2 or 3 per infected macrophage did not contribute 
any additional affect, possibly because of over-crowding and faster depletion of the media. 64 
 
 
Figure 3-1.  Co-culture of uninfected macrophages with Mtb-infected macrophages limits 
Mtb growth 
Thioglycollate-elicited peritoneal macrophages were infected with a 10:1 mulitplicity of 
infection (MOI) of H37Rv (left) or H37Ra for 4 hours before uninternalized bacteria were 
washed away and uninfected macrophages were added at a ratio of 2:1.  Bacterial burden was 
assessed at this point (day 0) and subsequent days as indicated.  Data is representative of 12 
experiments (left) or 4 experiments (right).  Error bars ± SEM.  *, p ≤ 0.05 Student’s t –test.   
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Thioglycollate-elicited peritoneal macrophages are highly activated due to the method of 
their retrieval from the mouse (unpublished observation).  As such, directly ex vivo they produce 
a measurable amount of nitric oxide.  Nitric oxide (NO) and reactive nitrogen intermediates 
(RNI) are potent antimycobacterial agents
9.  Because of this observation, we sought to confirm 
using other macrophage types that the co-culture of uninfected macrophages suppresses Mtb 
growth in ways other than or unrelated to NO production.  In fact the antibacterial activity was a 
feature of all types of macrophages tested, alveolar macrophages (Figure  3-2A), resident 
peritoneal macrophages (Figure  3-2B), RAW264 cells (Figure 3-2C) and the A3.1A7 bone 
marrow derived macrophage cell line
10 (Figure 3-2D).   These macrophage types are not ‘pre-
activated’ and produce no detectable NO prior to addition to the infected macrophage culture.  
Thus, under conditions in which we detect efferocytosis by microscopy,  bacterial growth is 
restricted.  Uninfected macrophage co-culture is capable of Mtb control. 
Macrophage activation does not boost antibacterial effect 
As we found that uninfected macrophages are capable of Mtb control, we asked if 
activating the macrophages could enhance their antibacterial effect.  Macrophages can be 
‘primed’ to upregulate antibacterial effector functions through a variety of means.  IFNγ/LPS 
priming increases NO production, and upregulates proteins involved in phagosome maturation.  
Treatment with heat-killed mycobacteria stimulates multiple TLRs and other pattern recognition 
receptors, ultimately activating inflammatory cytokines and readying the macrophage for 
bacterial encounter.  TNF treatment can lead to many outcomes, but in such a situation, NF-κB 
activation is dominant.  We activated uninfected macrophages with these three strategies prior to 
addition to infected macrophages as described above.  Pre-activating macrophages conferred no 
additional antibacterial properties to thioglycollate-elicited peritoneal macrophages (Figure 3-3).  
Similar results were obtained priming resident peritoneal macrophages.  This suggests that the  66 
 
 
Figure 3-2. Uninfected macrophage co-culture universally limits bacterial growth 
A.   Alveolar macrophages (aMφs), B. resident peritoneal macrophages (rMφs), C. RAW264.7 
macrophage cell line and D. A3.1A7 bone-marrow derived macrophage cell line (BMDM) were 
infected with an MOI of 10:1 Mtb for 4 hours before uninternalized bacteria were removed and 
uninfected macrophages of the same type were added.  Initial bacterial burden was assessed at 
time 0 (d0) or after 4 or 5 days (d4,5).  Data is representative of A,C, and D: 2 experiments; B: 3 
experiments..  Error bars ± SEM.  *, p ≤ 0.05, ***, p ≤ 0.0005 Student’s t –test.   
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antibacterial effector function expressed during efferocytosis cannot be upregulated by activating 
macrophages via conventional means that confer protection from primary tuberculosis infection.  
Thus, the antibacterial function mediated by efferocytosis appears to be constitutivly expressed 
by all macrophages.   
Apoptosis of infected macrophages is required if uninfected macrophages are to control 
Mtb growth 
To prove that efferocytosis is responsible for the bacterial control observed and not other 
contact dependent or independent mechanisms, we sought to block efferocytosis itself.  As 
efferocytosis requires the specific recognition and engulfment of apoptotic cells, we predicted 
that inhibition of apoptosis by caspase inhibitors would prevent efferocytosis and abrogate the 
CFU reduction mediated by uninfected macrophages.  Conversely, if bacterial control by 
uninfected macrophage co-culture were independent of apoptosis, caspase inhibition would have 
no effect on Mtb growth.  As demonstrated previously, inhibition of the intrinsic apoptosis 
pathway (caspase 9-dependent), but not the extrinsic pathway (caspase-8 dependent), reduced 
efferocytosis of Mtb-infected macrophages by uninfected macrophages.  Using the microscopy 
assay for efferocytosis we infected DiO-dyed macrophages with mCherry-H37Rv in the presence 
of caspase inhibitors.  Four hours later uninfected macrophages were added.  Sixteen hours later 
cells  were fixed and inspected by confocal microscopy.  The percent Mtb that had been 
efferocytosed of total Mtb in conditions in which caspase 3 and 9 were inhibited was 
significantly less than in the control treated conditions or caspase 8 inhibited condition (Figure 3-
4A).  Next we asked if caspase inhibition would likewise have an effect on CFU in the 
uninfected macrophage co-culture CFU assay. Caspase 3 and 9 inhibition abrogated CFU control 
observed following co-culture of infected and uninfected macrophages (Figure 3-4B).  Caspase  68 
 
 
Figure 3-3.  Macrophage activation confers no further antibacterial effect 
Uninfected macrophages were pre-treated for 6 hours with IFNγ/LPS (10U/mL, 10ng/mL), heat-
killed (HK) H37Ra sonicate (1µg/mL), TNFα (10ng/mL) or left untreated prior to addition to 
infected macrophages.  Bacterial burden was ascertained at days 0 (d0) and 4 post infection.  
Data is representative of 3 experiments.  Error bars ± SEM.  *, p ≤ 0.05 One-way ANOVA. 
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inhibition of infected macrophages, in the absence of uninfected macrophages had no effect on 
bacterial growth.  Thus, apoptosis is a prerequisite for restricting Mtb replication in our 
macrophage co-culture model.  As apoptosis is a prerequisite for efferocytosis, these results 
strongly suggest that efferocytosis is responsible for the control seen following uninfected 
macrophage co-culture.  
Efferocytosis controls Mtb growth   
Pro-inflammatory cytokines and immune mediators inhibit efferocytosis.  TNF and PGE2 
are widely reported to inhibit efferocytosis.  PGE2 is  known to inhibit efferocytosis in alveolar 
macrophages, thus we sought to inhibit efferocytosis  in our infected macrophage co-culture 
system by this strategy
11.  First we tested whether PGE2 was capable of inhibiting efferocytosis 
of apoptotic thymocytes in thioglycollate-elicited peritoneal macrophages (Figure 4-5A).  PGE2 
treatment resulted in greater than 50% reduction in efferocytosis, with only a minor impact on 
phagocytosis of heat killed E.coli.  Next we found PGE2 inhibited efferocytosis of Mtb-infected 
apoptotic macrophages in a dose-dependent manner (Figure 4-5B).  The inhibitory effect of 
PGE2  is thought to be mediated by increasing intracellular cAMP, a crucial regulator of 
engulfment  by phagocytes
12.  Thus, we showed that forskolin, a compound that causes an 
increase in intracellular cAMP, also inhibited efferocytosis.    This translated to a dose-dependent 
loss of control in the uninfected macrophage co-culture model (Figure 4-5C).  Uninfected 
macrophages that were pre-treated with PGE2 became unable to limit bacterial growth.  As the 
effects of efferocytosis inhibition caused by PGE2 has been defined in alveolar macrophages we 
asked if PGE2 treatment would inhibit uninfected alveolar macrophage co-culture control of Mtb 
growth.  PGE2 treatment of uninfected alveolar macrophages prevented their ability to restrict 
bacterial growth in vitro (Figure 4-5D). In several experiments co-culture of uninfected and  70 
 
 
Figure 3-4. Apoptosis is required for uninfected macrophage control over Mtb growth 
A.  DiO-dyed macrophages were infected with mCherry-H37Rv for 4 hours before uninfected 
CD45.1 macrophages and the indicated caspase inhibitors (10µM) or control peptide (ctrl) was 
added.  Cells were fixed and stained for CD45.1 16 hours later.  Efferocytosis was enumerated as 
the percent of Mtb that had been efferocytosed of total Mtb.  Data is representative of 3 
experiments.  B.  Macrophages were infected with H37Rv as described in the presence of 
caspase inhibitors as indicated before addition of uninfected macrophages.  Bacterial burden was 
determined at day 0 (d0) and 5.  Data is representative of 4 experiments.  Error bars ± SEM.  *, p 
≤ 0.05; ns, not significant. One-way ANOVA. 
   71 
 
infected macrophages significantly reduced the number of recovered bacteria to below the level 
of the initial inoculums, which is indicative of bacterial killing, a phenomenon observed in other 
studies
8.  Thus efferocytosis is a potent mechanism of Mtb growth suppression in alveolar 
macrophages. 
To prove that efferocytosis was required for bacterial growth restriction, we sought to 
more specifically inhibit the engulfment process itself.  Most macrophages express a variety of 
redundant receptors that mediate the recognition and uptake of apoptotic cells
13 and inhibition of 
any individual receptor yielded little or no inhibition of apoptotic thymocyte uptake by pMφs in 
a non-infectious model of efferocytosis (data not shown).  An early event during apoptosis is 
phosphatidylserine (PS) flipping to the outer leaflet of the plasma membrane.  PS is a ligand for 
many efferocytosis receptors and bridging molecules that aid in apoptotic cell recognition and 
engulfment
14,15.  Resident peritoneal macrophages rely primarily on the PS receptor TIM4 to 
recognize apoptotic cells and to mediate efferocytosis
16,17. Blocking TIM4 in resident peritoneal 
macrophages significantly reduced efferocytosis of Mtb-infected apoptotic cells (Figure 3-6A). 
TIM4 blockade also significantly increased the incidence of secondarily infected cells (Figure 3-
6A). This occurs presumably because the failure to clear apoptotic cells leads to more secondary 
necrosis and dispersal of intracellular contents including Mtb.  Importantly, blocking TIM4 
reduced the ability of uninfected resident peritoneal macrophages to restrict bacterial growth 
(Figure 3-6B).  Thus engulfment of apoptotic cells specifically is responsible for the majority of 
the control exerted by uninfected macrophage co-culture.  These data demonstrates for the first 
time that efferocytosis is an innate antibacterial mechanism.  Apoptosis itself is not directly 
bactericidal as it has long been assumed, as engulfment is required for control.  Additionally, in 
the absence of apoptotic cell clearance Mtb spread into surrounding uninfected macrophages thus  72 
 
 
Figure 3-5.  PGE2 inhibits efferocytosis  
A.  Macrophages were treated with 1µM PGE2 for 4 hours before addition of heat killed E.coli 
or DiO-dyed apoptotic thymocytes for 1 hour.  Cells are gated as total cells, live cells, single 
cells, F4/80
+.  Data is representative of 3 experiments.  B.  Uninfected Mφs were treated for 4 
hours with indicated concentrations of PGE2 or 100µM forskolin before addition to mCherry-
H37Rv-infected Mφs.  Efferocytosis was measured 16 as previously described.  Data is 
representative of 3 experiments. Error bars ± SEM.  *, p ≤ 0.05 One-way ANOVA. 
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further broadcasting the infection.  Thus,  efferocytosis is an important innate immune 
mechanism of bacterial control and is one that can be used by alveolar macrophages to control 
Mtb growth or even mediate bacterial killing.  Efferocytosis is a constitutive function of 
macrophages that cannot be primed or activated by cytokines that traditionally activate 
antibacterial effector functions in macrophages.  This explains why we were unable to elicit 
more control in the infected macrophage co-culture  system  following  IFNγ  or  TNF  pre-
treatment.   
 
Discussion 
  It has long been assumed that apoptosis is capable of killing Mtb; however a mechanism 
for this control has never been provided.  Additionally, other forms of cell death, such as 
necrosis hav no adverse effect on bacterial survival.  In early studies the induction of apoptosis in 
BCG-infected macrophages lead to bacterial killing
5.  However in this study they reported 
efferocytosis of apoptotic BCG infected macrophages visualized by transmission electron 
microscopy.  The investigators did not consider that efferocytosis could be contributing to 
control.  Other reports induced apoptosis with Fas ligand and reported Mtb control
6.  In this 
study, a minority of macrophages following this treatment underwent apoptosis as determined by 
Annexin V staining.  Thus uninfected macrophages could participate in control of Mtb.  Previous 
reports indicated that addition of uninfected macrophages to Mtb-infected macrophages 
suppressed bacterial growth
7,8.  Based on our finding that apoptosis infected macrophages are 
engulfed by efferocytosis (Chapter 2), we hypothesized that efferocytosis might link apoptosis 
and bacterial killing, and explain the antibacterial effect of uninfected macrophages. 
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Figure 3-6. PGE2 abrogates uninfected macrophage co-culture control of Mtb growth 
A.  Macrophages were infected with H37Rv before uninfected Mφs  pre-treated with indicated 
concentrations of PGE2 for 4 hours were added.  CFU was determined at time 0 (d0) and day 7.  
Data is representative of 3 experiments.  B.  Alveolar macrophages (aMφs) were infected with 
H37Rv before addition of uninfected aMφs, treated with 1µM PGE2 as indicated.  CFU was 
determined at time 0 and day 5.  Data is representative of 2 experiments.   Error bars ± SEM.  *, 
p ≤ 0.05 One-way ANOVA. 
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Figure 3-7.  Efferocytosis controls Mtb growth 
A.   rMφs were infected according to the confocal microscopy assay in the presence of 10µg/mL 
TIM4 blocking antibody 5G3 or rat IgG1 and efferocytosis and secondary infection was 
enumerated as previously described.  Data is representative of 3 experiments.  B.  rMφs were 
infected according to the efferocytosis assay in the presence of αTIM4 or IgG as indicated and 
CFU were plated in quadruplicate on days 0 and 6 post infection.  Data is representative of 4 
experiments.  Error bars ± SEM.  *, p ≤ 0.05 One-way ANOVA. 
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  We confirmed that the addition of uninfected macrophages in excess of Mtb-infected 
macrophages limits bacterial growth in vitro.  We extended this observation by finding that 
control was uniformly observed across all macrophage types tested.  We could not further 
enhance the antibacterial effector function of uninfected macrophages by priming and activation 
with stimuli such as IFNγ, LPS, or heat killed mycobacteria.  This suggested to us that the 
antibacterial mechanism cannot be further induced, and thus might not belong to one of the 
known antibacterial pathways.  However, this does not exclude the possibility of other untested 
stimuli boosting the effect.  The amount of bacterial control following uninfected macrophage 
co-culture is similar to the level of control seen following infected macrophage treatment with 
IFNγ/LPS, suggesting that the effect of uninfected macrophage co-culture is just as potent as one 
of the paramount cytokines in protection from tuberculosis.   
  Our prior work implicated efferocytosis as a potential bacterial control mechanism. To 
confirm this, we sought to inhibit efferocytosis, which we did by targeting three mechanisms. 
First, inhibition of apoptosis limited efferocytosis, and also limited the ability of uninfected 
macrophages to control Mtb CFU in the co-culture system.  Second, we inhibited efferocytosis 
via PGE2 signaling.  PGE2 and other pro-inflammatory cytokines downregulate the efferocytic 
machinery.  Specifically, high concentrations of PGE2 cause an intracellular flood of cAMP, 
which inhibits the engulfment of apoptotic cells.  While a non-specific effect, we found that 
PGE2 limited efferocytosis, and efferocytosis-mediated control.  Importantly, we demonstrated 
that alveolar macrophages are capable of controlling Mtb by efferocytosis.  To definitively 
demonstrate that efferocytosis is required for control in the infected macrophage co-culture 
system we sought to inhibit efferocytosis specifically, which we chose to do by blocking a well-
known efferocytosis receptor. TIM4.  Inhibiting efferocytosis by blocking TIM4-PS interaction 77 
 
abrogated control in the macrophage co-culture system, indicating that efferocytosis is a 
mechanism of Mtb control. 
Inhibiting efferocytosis was difficult, as macrophages employ multiple receptors to 
mediate recognition and engulfment of apoptotic targets.  Downstream of many efferocytosis 
receptors is Rac1, a small GTPase responsible for organizing the actin cytoskeleton during 
efferocytosis
18.   We attempted to target Rac1.  Amiloride inhibits Rac1 activity by causing a pH 
increase proximal to the plasma membrane which blocks Rac1 activation
19.  In a FACS based 
assay we were able to inhibit macrophage efferocytosis of apoptotic thymocytes.  However, 
amiloride is toxic over long periods, and thus we were unable to test its effects in a CFU assay.  
This was true of many inhibitors known to act on proteins crucial during efferocytosis.  Rac1 
knockdown with siRNA were never complete, potentially due to the high expression of Rac1 in 
most primary macrophages.  Knockdown of Rac1 effectors such as Cdc42 was also unsuccessful.  
Thus we turned our attentions on inhibiting apoptotic cell recognition by blocking the 
‘efferocytosis receptors’.  TIM4 was recently described as recognizing PS exposed on the surface 
of dying cells
16.  Using a TIM4 blocking antibody previously shown
20 to inhibit efferocytosis we 
demonstrated that uninfected macrophages were indeed engulfing Mtb-infected apoptotic cells.  
Furthermore, inhibition of efferocytosis increased secondary infection as apoptotic cells 
proceeded to a secondary necrotic state, spilling their intracellular contents and allowing for 
bacterial spread.   
These data fundamentally change our view of apoptosis during intracellular infection. 
This is the first report of efferocytosis acting an antimicrobial effector mechanism.  Our work 
suggests that any beneficial effect of apoptosis on host resistance to infection may ultimately be 
mediated by efferocytosis.  This is not just limited to innate control of microbial infection.  This 78 
 
report has focused on the role of macrophage apoptosis as an innate response following Mtb 
infection.  However, the killing of infected cells is an important effector mechanism of the 
adaptive immune response to tuberculosis
21.   CD8
+ T cells can induce death in target cells via 
the release of cytotoxic granules containing granzymes or through the engagement of surface 
receptors containing death domains such as CD95/95L
22,23.  Both of these pathways lead to 
apoptotic death in the target cells.  We envision that the capacity of cytotoxic T lymphocytes 
(CTL) to kill infected cells restricts bacterial growth indirectly since the induction of apoptosis in 
the infected cells will facilitate their engulfment by uninfected macrophages recruited to 
inflammatory foci.   
Our conclusions force one to consider whether efferocytosis is a mechanism that can be 
exploited or subverted by pathogens to evade host immunity during their life cycle.  For 
example, Leishmania employ neutrophil apoptosis and subsequent efferocytosis as a mechanism 
of establishing infection within macrophages
24,25.  Indeed, some pathogens might rely on uptake 
of infected dying cells to spread the infection, as is the case in M. marinum infection of zebrafish 
embryos
26.  Efferocytosis may control or exacerbate many infectious diseases and it will be 
important to explore how macrophages contribute to microbial immunity in this way.   
There are a few reports suggesting that dead cell debris hinders bactericidal mechanisms 
in macrophages.  During Francisella infection dead cell debris stimulates arginase activity in 
macrophages which impairs bacterial clearance while inducing an alternatively activated “M2” 
phenotype
27.   In alternatively activated macrophages iNOS is downregulated in favor of arginase 
activity.  Arginase activity is not damaging to Mtb
28.  Thus we do not believe that an alternative 
activation state is contributing to bacterial control in this system and we did not pursue this line 
of inquiry further.  In another model, efferocytosis of apoptotic cells impaired macrophage-79 
 
mediated killing of Streptococcus pneumoniae, by perturbing inflammatory cytokine 
production
29.  Mtb and S. pneumoniae killing must proceed via different mechanisms.  This is 
potentially due to the very different lifestyles of these two pathogens.  S. pneumoniae is not an 
intracellular pathogen, and it can be killed by phagocytosis and other antibacterial effector 
functions of the macrophage that might be downregulated by efferocytosis
30,31.    
Recently, mechanisms for increasing macrophage efferocytic ability have been described.  
If these mechanisms could be harnessed to increase the efficiency of efferocytosis in vivo during 
active tuberculosis both the spread of infection and inflammation-induced damage could both be 
quelled.  Engulfing such a large target causes great stress to the efferocytic macrophage.  
Maintenance of the mitochondrial membrane potential is tied to efficient efferocytosis
32.  
Perhaps modulating the mitochondrial membrane potential could enhance macrophage’s 
efferocytic capacity that might otherwise be overwhelmed during disease.  Lovastatin has been 
shown enhance efferocytosis as well
33.  Lovastatin inhibits RhoA, which negatively regulates 
Rac1
34,35.   The potential contribution of statins during active tuberculosis disease is unexplored.  
However, statin use does protect against influenza, an infection that is killed by efferocytosis
36-38.  
Thus our work further demonstrates that how surrounding cells recognize and react to the death 
of an infected cell can modulate the outcome of infection.  Efferocytosis emerges as a novel 
mechanism of microbial control.  
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Methods 
Mice and macrophage isolation 
C57Bl/6 (CD45.2) and B6.SJL-Ptprc
a Pepc
b/BoyJ (CD45.1) mice were purchased from Jackson 
Laboratories (Bar Harbor USA), and were kept and bread using standard humane animal 
husbandry protocols.  Mtb-infected mice were housed under BSL3 conditions. Thioglycollate-
elicited peritoneal Mφs (pMφs) were lavaged from peritoneal cavities 4-5 days following 3% IP 
thioglycollate injection.  Mφs were isolated using CD11b microbeads and magnetic columns 
(Miltenyi Biotec) and cultured in 24 or 96 well dishes overnight prior to infection.  Resident 
peritoneal  Mφs  (rMφs)  were  lavaged  from  peritoneal  cavities  and  selected  based  on 
CD11b
+CD19
-.  Alveolar Mφs (aMφs) were lavaged from the lungs of mice with PBS.   
Mtb culture and infection 
mCherry-H37Rv was cultured with 0.5ug/mL Hygromycin B.  Mtb infection was conducted as 
previously described
39 with the following modifications.  Mφs were grown in 24- or 96-well 
plates and infected at a multiplicity of infection (MOI) of 10:1 for 4 hours.  Cultures were then 
washed 3-5 times.  Efferocytic Mφs were added at 2x the number of infected Mφs.  As indicated 
efferocytic  Mφs  were  pretreated  with  10µM PGE2  for 4 hours at 37
oC before washing and 
addition to infected Mφs.  Caspase inhibitors (Calbiochem) (10µM), αTIM4 (10µg/mL- kind gift 
of Vijay Kuchroo, Harvard Medical School) or rat IgG1 (10µg/mL) were added following 
infection.  CFU were determined immediately following infection and at indicated timepoints per 
condition in quadruplicate by removing culture supernatant, lysing Mφs with 1% TritonX/PBS 
solution, plating serial dilutions on 7H11 plates and incubating at 37
oC/5% CO2 for 3 weeks.  All 
Mtb strains were confirmed by thin layer chromatography to be PDIM
+.   
FACS efferocytosis assay 81 
 
Apoptotic thymocytes were generated by dying thymocytes with 1µM CFSE or 1:1000 Vybrant 
DiO (Invitrogen) prior to apoptosis induction with staurosporine for 6-16 hours.  Thymocytes 
were then co-cultured with macrophages at a ratio of 5:1 for 1 hour in 24 well plate before 
washing, staining with antibodies directed against F4/80, fixation and analysis on a BD FACS 
CANTO II and FlowJo software.  Heat killed E.coli Bioparticles (Invitrogen) were added as a 
control. 
Confocal microscopy efferocytosis assay 
Mφs  from  CD45.2  mice  were  cultured  in  24  well  dishes  in  triplicate  per  condition  upon 
coverglass and dyed with Vybrant DiO as per manufacturer’s specifications prior to infection 
with mCherry-H37Rv or GFP-H37Rv for 4 hours.  Uninternalized bacteria were washed away 
and  uninfected  CD45.1  Mφs  were  added  at  2x  the  number  of  infected  Mφs.    Treatment 
conditions were added as appropriate.  16-24 hours later cells were washed and stained with 
mouse monoclonal CD45.1 (Abcam) before affixing to microscopy slides with Prolong Gold 
plus DAPI (Invitrogen).  Conditions were analyzed in triplicate and for each replicate in each 
condition 100-300 Mtb were counted.  Images were taken using a Nikon TE2000-U inverted 
microscopy equipped with C1 Plus confocal laser scanner. 
Image Analysis 
Microscopy images were analyzed using Image J
40 and colocalization analysis macros or user-
generated pipelines in Cell Profiler
41.  Investigators were blinded during analysis.   
Statistical Analysis 
Statistical analysis and graphical output was done with GraphPad Prism.  One-way ANOVA 
with Dunnet’s post-test.  * = p≤0.05 
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Abstract 
 
Mycobacterium tuberculosis (Mtb) subsists within macrophages in an arrested phagosome to 
secure a protective niche for its survival and growth.  To disseminate the infection Mtb induces 
the cell death of its host macrophage; however apoptotic death is associated with decreased 
bacterial survival.  We previously reported that apoptosis is not intrinsically bactericidal, but that 
efferocytosis of Mtb-infected apoptotic macrophages by uninfected macrophages is responsible 
for suppressing bacterial growth.  Efferocytosis, the engulfment of apoptotic cells, results in the 
destruction of the ingested target via phagosome maturation.  We report here that Mtb engulfed 
within apoptotic cells are incapable of inhibiting phagosome maturation and lysosome fusion.  
Thus, following efferocytosis we find that Mtb is killed.  We present here efferocytosis as a novel 
bactericidal mechanism. 
 
Introduction 
   
  Mycobacterium tuberculosis, the causative agent of tuberculosis responsible for nearly 2 
million deaths world-wide, is a facultative intracellular pathogen that inhibits phagosome 
maturation in the host macrophage.  Typically, after ingesting a bacterium, foreign particle or 
apoptotic cell, the macrophage encases the target within a phagosome that successively ‘matures’ 
by fusing with, and acquiring characteristics of the lysosome.  This maturation process results in 
a phagolysosome competent to destroy the engulfed cargo; it is acidic and contains microbicidal 
and hydrolytic enzymes.  The macrophage is ultimately responsible for bacteria and debris 
removal, yet Mycobacterium tuberculosis (Mtb) exploits the intracellular environment for its 
protection and survival.  From within the arrested phagosome Mtb replicates and eventually 
causes the death of its host macrophage as the bacteria spread to new macrophage hosts. 88 
 
  Mtb possesses several virulence factors that have been described as crucial for inhibiting 
phagosome maturation. For one, mannosylated lipoarabinomannan (ManLAM), a lipid present 
on Mtb’s surface that is chemically similar to phosphatidyl-inositols (PI), such as PI(3)P, which 
is required for Early Endosome Antigen 1 protein (EEA1) recruitment and phagosome 
maturation 
1.  ManLAM intercalates into host membrane and inhibits the PI(3)P kinase Vps34 on 
the phagosome membrane from depositing PI(3)P on the membrane and thus blocking EEA1 
recruitment 
2, 3.  SapM a lipid phosphatase, works by cleaving PI(3)P on the phagosome 
membrane, which similarly prevents EEA1 deposition on the membrane 
4.  Trehalose dimycolate 
(TDM, cord factor) is a crucial cell wall lipid in Mtb that inhibits phagosome maturation 
5.  TDM 
suppresses phagosome maturation through an unknown mechanism, although reactive nitrogen 
and oxygen species produced by activated macrophages can dismantle TDM and its functionality.  
The failure of lysosome and endosome fusion prevents the delivery of catabolic enzymes and the 
vacuolar ATPase (vATPase) responsible for acidifying lysosomal compartments 
6.  The Mtb-
containing phagosome characteristically is stuck in an altered early endosome state- decorated 
with GTPases of the Rab family, specifically Rab5, lacking Rab7, near neutral in pH, showing 
little to no Lysosomal-associated membrane protein 1 (LAMP1) and cathepsin recruitment, but 
accessible to the recycling endocytic pathway that delivers transferrin complexed to iron to the 
bacilli 
7-10.  Clearly phagosome maturation arrest is a crucial aspect of Mtb’s virulence strategy as 
the bacteria employs many methods to halt phagosome maturation and still more await discovery.  
Mtb is not resistant to macrophage-mediated killing once delivered to the lysosome.  In fact, 
IFNγ treatment induces phagolysosome maturation and Mtb killing 
11.  Thus, while the bacteria 
are uniquely capable of halting phagosome maturation, the macrophage is not entirely without 
defenses. 89 
 
  Apoptosis has been described previously to suppress Mtb growth, both in vivo and in 
vitro 
12, 13.  While it was long assumed that apoptosis is intrinsically bactericidal, we have shown 
that this is not the case.  The bactericidal effect of apoptosis is exclusively mediated by 
efferocytosis, the process of apoptotic cell engulfment by macrophages.  We found that Mtb-
containing apoptotic blebs are engulfed by uninfected macrophages and that this process leads to 
a suppression of Mtb growth in vitro.  Efferocytosis is a remarkably fast process, as is the 
acidification of the efferocytic phagosome, the compartment that contains the engulfed apoptotic 
cell 
14.   Efferocytosis leads to the efficient destruction of the internalized cell.  This process must 
be fast, as macrophages may encounter several dead and dying cells in short succession, 
especially during development and the resolution of infection 
15.  Although the receptors 
mediating apoptotic cell recognition are different than phagocytic receptors, once internalized, 
the basic machinery is the same 
16.  Rab proteins are successively recruited, ensuring the fusion 
of lysosomes bearing degradative enzymes and ER-derived vesicles harboring the vATPase, 
responsible for acidification and activation of hydrolytic enzymes.   
  In this chapter we further define the antibacterial properties of efferocytosis.  We report 
that the efferocytic phagosome containing Mtb is distinct from the traditional Mtb-containing 
phagosome.  This structure is efficiently delivered to acidic compartments and acquires 
lysosomal markers.  We find that at the single cell level following efferocytosis Mtb is killed 
within lysosomes.  Thus we report that efferocytosis is not just capable of bacterial growth 
suppression, but is a novel bactericidal mechanism. 
 
Results 
 
Mtb and cell debris are found within vacuous phagosomes following efferocytosis 90 
 
Given that efferocytosis of an Mtb-infected apoptotic cell exerts significant control over 
Mtb growth, we sought to understand what is unique about efferocytosis that could restrict 
bacterial growth.  We asked whether the intracellular compartments containing Mtb differed 
following internalization by phagocytosis versus efferocytosis.  Using transmission electron 
microscopy (TEM) we confirmed that one day post-infection, Mtb was contained behind a tight-
fitting phagosome membrane closely juxtaposed to the bacterial membrane, as has been 
previously seen 
17 (Figure 4-1A).  By electron microscopy Mtb within macrophages have a 
characteristic bright white electron lucent zone surrounding the dark and electron dense bacterial 
body.  This is a property of the bacteria’s highly lipidic cell wall that does not embed optimally in 
the epoxy resin.  The electron lucent zone does not represent ‘empty space’ and is an artifact of 
the procedure.   Mtb were also intact and showed no sign of digestion.  Following efferocytosis, 
apoptotic thymocytes within uninfected macrophages occupied very different phagosomes 
(Figure 4-1B).  Characteristically, the efferocytic phagosome is vacuous, with fluid filling the 
space between apoptotic cell membrane and phagosome membrane
18.  This fluid-filled space is 
not the same as the electron lucent zone that surrounds the mycobacterial body.  For one, the 
space is not bright white, indicating that the resin properly infiltrated the space.  It shows the 
same electron density as the resin itself, as indicated by the extracellular space between 
macrophages in the resin.  Other techniques besides electron microscopy have described a 
vacuous efferocytic phagosome as well
19.  Thymocytes, as well as apoptotic macrophages were 
found in various states of digestion and destruction of both organelle and plasma membranes 
(Figure 4-1B,C).  Note that the cytosol for both the apoptotic thymocyte and macrophage bleb 
closest to the plasma membrane (PM) resembles the cytosol of the efferocytic macrophage, as 
these blebs are most likely newly engulfed and have yet to experience lysosomal fusion and  91 
 
 
Figure 4-1.  The Mtb phagosome is distinct from the efferocytic phagosome 
A.   Transmission electron micrograph of Mtb within a primary infected thioglycolate-elicited 
peritoneal macrophage (pMφ)  stained with lead citrate.  B.  Apoptotic thymocytes co-cultured 
with pMφs for 1 hour prior to fixation. Note the three thymocyte apoptotic blebs in increasing 
stages of digestion and disintegration.  C.  Mtb infected pMφs co-cultured with uninfected pMφs 
16 hours.  Apoptotic pMφ blebs within uninfected pM.  Asterisks,  Mtb; arrows, phagosome 
membrane; PM, plasma membrane; scale bar, 1µM.  Images are representative of >1000 
macrophages over many non-serial 60nm sections and 2 independent experiments. 
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degradation.  The blebs further inside the macrophages show increasing levels of digestion; both 
their cytosol and intracellular membranes show progressive levels of destruction and 
disintegration. 
After overnight co-culture of Mtb-infected and uninfected macrophages, Mtb was found 
within efferocytosed apoptotic blebs encased within a spacious phagosome (Figure 4-2A).  This 
spacious phagosome was very reminiscent of the efferocytic phagosomes containing apoptotic 
thymocytes and macrophage blebs.  Note that the characteristic electron lucent zone surrounding 
the bacteria (two are visible, viewed head-on) is intact, indicating that the bacteria are still viable.  
It was difficult to determine if a phagosome membrane surrounds the Mtb within the apoptotic 
bleb.  As the subcellular location of Mtb just prior to cell death is unknown, we chose to not 
investigate this observation further.  Additional membranes and intact cellular components were 
discerned within these apoptotic blebs along with Mtb, indicating an early stage of digestion 
(Figure 4-2A).  Thus, the efferocytic Mtb phagosome is structurally distinct from a bacterium 
within a primary infected macrophage.  Mtb is taken up within an apoptotic bleb, and not simply 
amongst dead cell debris. Damaged Mtb with characteristic ‘onion’ morphology were also 
observed within vacuous phagosomes along with cellular debris, possibly indicating killed 
bacteria following efferocytosis
20 (Figure 4-2B).  Damaged Mtb also lack the electron lucent 
zone characteristic of their lipidic coat, further suggesting that these bacteria are not viable.  
Finding damaged Mtb in the efferocytic condition was common, but never seen in the primary 
infected macrophage condition. This raised the possibility that bacteria efferocytosed within 
apoptotic macrophage blebs are processed differently than phagocytosed bacteria.  In fact, 
damaged bacteria with the ‘onion’ morphology have a strong correlation with lysosomes
20.  This  
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Figure 4-2.  Mtb are found within vacuous efferocytic phagosomes along with cell debris 
following uninfected macrophage co-culture 
A. Mtb within vacuous efferocytic phagosomes along with apoptotic bleb after the co-
culture of uninfected thioglycollate-elicited peritoneal macrophages (pMφs) with infected pMφs.  
Note cellular structures still visible within apoptotic bleb.  B.  Mtb showing characteristic 
degraded phenotype following efferocytosis.  Note the vacuous phagosome containing cell debris.  
Asterisks,  Mtb; white arrows, efferocytic phagosome membrane; black arrows, apoptotic bleb 
membrane; PM, plasma membrane; scale bar, 1µM.  Images are representative of >1000 
macrophages over many non-serial 60nm sections and 2 independent experiments. 
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suggests that efferocytosis of Mtb containing blebs fuse with lysosomes more readily than Mtb 
phagosomes.   
 
The Mtb-efferocytic phagosome matures and acquires lysosomal characteristics 
Mtb possesses virulence factors that subvert phagosome maturation and allow it to 
exploit the intracellular environment of the macrophage.  It is not completely understood how 
Mtb delivers its virulence factors to their host targets, both for the suppression of phagosome 
maturation and cell death induction.  Even so, we reasoned that the uptake of Mtb contained 
within an apoptotic cell further compartmentalizes the bacteria and limits its ability to interfere 
with phagosome maturation.  To this end we measured the co-localization of Mtb with markers 
of mature lysosomes following efferocytosis (Figure 4-3A).  Bone marrow-derived macrophages 
were infected with mCherry-H37Rv and then co-cultured with uninfected CD45.1 macrophages.  
Sixteen to twenty hours later the cells were fixed and stained with antibodies to LAMP1, a 
marker of lysosomes, as well as CD45.1 to differentiate the primary infected macrophages from 
the uninfected added macrophages.  In this assay efferocytosis cannot be distinguished from 
secondary infection, as our confocal microscope is limited to three colors.  In all previous 
experiments (Chapters 2 & 3) efferocytosis outnumbers secondary infection 2-3:1, making it the 
dominant phenotype of Mtb within the CD45.1 macrophage population.  Also, prior experience 
found that inhibiting efferocytosis by inhibiting apoptosis (caspase 3 inhibitor) and PGE2 pre-
treatment severely limited the amount of efferocytosis without significantly impacting secondary 
infection.  Thus it is important to compare the amount of Mtb-lysosome co-localization in pro-
efferocytosis conditions and efferocytosis inhibitory conditions.  Using this assay we found more 
Mtb within efferocytic (CD45.1) bone marrow-derived macrophages co-localized with LAMP1 
than in primary infected macrophages (Figure 4-3B).  Inhibiting apoptosis (with a caspase 3  95 
 
 
Figure 4-3.  Mtb are present in LAMP1
+ compartments following efferocytosis 
A.  Mtb within a LAMP1+ vesicle.  Mtb (red), LAMP1 (green), CD45.1 (far red/pseudocolor 
blue) and merge.  Bone marrow-derived macrophages (BMDMφs) were infected with mCherry-
H37Rv for 4 hours prior to uninfected CD45.1+ BMDMφ addition.  24 hours later cells were 
fixed and stained for LAMP1 and CD45.1 and visualized by confocal microscopy.  B.   
Quantification of (A).  Percentage of Mtb co-localizing with LAMP1 of total Mtb counted in 
either primary infected  BMDMφs  alone  (clear  bar)  or  in  CD45.1+  BMDMs  (filled  bars) 
following co-culture.  Caspase inhibitor (10µM) added at time of co-culture.  Uninfected 
macrophages pre-treated with PGE2 (10µM) for 4 hours prior to addition to infected BMDMφs.  
100-200 Mtb were counted per condition in triplicate.  Data is representative of 4 experiments.  
Error bars ± SEM, *, p ≤ 0.05, One-way ANOVA with Dunnet’s post-test. 
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inhibitor) or efferocytosis (with PGE2) both reduced the Mtb-LAMP1 co-localization back to 
levels characteristic of primary infection.   
The vacuolar ATPase is responsible for maintaining the acidic pH of the lysosomal 
compartment.  Acidification limits bacterial growth, but more importantly activates degradative 
lysosomal proteins responsible for dismantling internalized bacteria and apoptotic cells alike.  
Mtb specifically exclude the vATPase from its phagosome to prevent acidification and lysosomal 
protein activation
6.  Following efferocytosis, there was greater Mtb-vATPase co-localization in 
efferocytic (CD45.1) macrophages than in primary infected macrophages (Figures 4-4A,B).  
Ultimately, low pH marks a functional, mature lysosome.  Following efferocytosis more Mtb co-
localize with LAMP1 and vATPase; therefore,  we reasoned that Mtb would also be present 
within acidic vesicles as well.  Thioglycollate-elicited peritoneal macrophages were infected with 
GFP-H37Rv for four hours prior to uninfected macrophage addition.  The following day cells 
were incubated for two hours with Lysotracker Red, a cell permeable compound that is 
preferentially sequestered within acidic compartments.  The Mtb-containing phagosome limits 
acidification; however, more Mtb were detected within acidic compartments following 
efferocytosis as determined by Mtb-Lysotracker co-localization (Figures 4-5A,B).  We could not 
determine whether Mtb-Lysotracker co-localization occurred more frequently in efferocytic 
(CD45.1) macrophages compared to primary infected macrophages because antibody staining of 
Lysotracker-Red-labeled cells is not technically possible.  Instead, we quantified the difference in 
Mtb-Lysotracker co-localization between primary infected macrophages verses infected 
macrophages with uninfected macrophages co-cultured (which favors efferocytosis).  Many 
bacteria were within large acidified vesicles (arrow),  reminiscent of the vacuous efferocytic 
phagosomes observed by confocal and electron microscopy.  Blocking efferocytosis reduced the  97 
 
 
Figure 4-4.  Mtb co-localizes with vacuolar ATPase following efferocytosis 
A. Mtb co-staining with ATP6v1B2 subunit of the vATPase in bone marrow-derived 
macrophages (BMDMφs) following uninfected Mφ (CD45.1) co-culture with infected Mφ.  Mtb 
(red), vATPase (green), CD45.1 (far red/pseudocolor blue) and merge.  Co-localization was 
determined using co-localization analysis scripts in ImageJ.  B. Quantification of (A).  Percent 
Mtb-vATPase co-localization of total Mtb within either primary infected BMDMφs (clear bar) or 
CD45.1
+ BMDMφs (filled bar).  100 Mtb were counted per Mφ type in triplicate.  Data is 
representative of 2 experiments.  Error bars ± SEM, p ≤ 0.05, Student’s t-test. 
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bacteria’s co-localization with acidic compartments to levels seen in primary infection.  
Treatment with bafilomycin, an inhibitor of the vATPase severly limited Mtb-Lysotracker co-
localization and disrupted Lysotracker
+Mtb
-  compartments, indicating that our staining was 
specific for acidified compartments. The fusion of lysosomes with the efferocytic phagosome 
delivers catabolic enzymes capable of destroying the bacterium.  These data demonstrate that 
Mtb is unable to inhibit maturation of the efferocytic phagosome, exposing the bacterium to the 
caustic environment of degradative lysosomes.   
Components of the autophagic machinery have been implicated in facilitating phagosome 
maturation, efferocytic phagosome maturation and Mtb control
21-23.  However, no specific 
enrichment of LC3 (Microtubule-associated proteins 1A/1B light chain 3/Atg8), an early marker 
of autophagosomes, was found on Mtb-containing phagosomes following efferocytosis (Figures 
4-6A,B).  Additionally, contrary to Martinez et al
22, LC3 was not found recruited to the 
efferocytic phagosome containing apoptotic thymocytes, ruling out autophagic machinery 
involvement in this model of efferocytosis as well (Figure 4-6C).  Rapamycin was used as a 
positive control for Mtb-LC3 co-localization. Rapamycin inhibits mTOR, a complex that sits at 
the top of nutrient sensing within cells, and is well known to induce robust autophagy, did 
increase LC3 co-localization with Mtb, as did overnight serum starvation.  These data suggest 
that autophagy plays no special role in efferocytosis of Mtb-containing apoptotic blebs.      
 
Efferocytosis kills Mtb on a single-cell level 
Phagosome maturation is capable of killing Mtb, thus we hypothesized that efferocytosis 
of Mtb-containing apoptotic cells does not just suppress bacterial growth, but destroys the 
bacteria.   To determine the effect of efferocytosis on bacterial viability at the single cell level,  99 
 
 
Figure 4-5.  Mtb co-localizes with acidic compartments following efferocytosis 
A.  Mtb within an acidic compartment (arrow) in thioglycollate-elicited peritoneal macrophages 
(pMφs).  Mtb (green), Lysotracker (red) and merge.  B.  Percent Mtb within acidic compartments 
of total Mtb counted per condition in pMφs.    Efferocytosis was inhibited with 10uM caspase 3 
inhibitor or uninfected macrophage PGE2 pre-treatment.  Bafilomycin (1µM) was added for 2 
hours before and during the assay.  150 Mtb were counted per condition in triplicate.  Data is 
representative of 2 experiments. Error bars ± SEM, p ≤ 0.05, One-way ANOVA with Dunnet’s 
post-test. 
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Figure 4-6.  LC3 is not recruited to the Mtb-containing efferocytic phagosome 
A.  Co-localization and no co-localization of Mtb with LC3 in thioglycollate-elicited peritoneal 
macrophages (pMφs).  Mtb (red), LC3 (green) and merge.  B.  Percentage of Mtb co-localizing 
with LC3 of total Mtb per macrophage type: primary infected macrophage, clear bar; CD45.1 
macrophages, filled bar. Uninfected CD45.1 pMφs were added to infected pMφs and 16 hours 
later stained for LC3.  Rapamycin (50µg/mL) was added for 4 hours prior to induce autophagy.  
300 Mtb were counted per condition in triplicate.  Data is representative of 2 experiments.   
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we infected macrophages with H37Rv that constitutively express mCherry (red) and inducibly 
express GFP (green) using a Tet
ON (tetracycline-inducible) promoter. After tetracycline induction 
‘live’ bacteria expressed both red and green fluorescent proteins while bacteria that are dead only 
fluoresced red (Figure 4-7A).  We confirmed that changes in viability observed using the 
live/dead reporter Mtb correlate with changes in CFU (Figure 4-7B).  Bacteria in macrophage 
culture treated with rifampin caused a 20% reduction in both CFU and viability as determined by 
the live/dead reporter and microscopy.  Thus live/dead Mtb are a valuable tool for assessing the 
viability of Mtb on a single cell level.  However, bacterial killing is accompanied with digestion 
of the bacterium and the mCherry protein.  With time there is a loss of signal, thus while the 
live/dead reporter remains a valuable tool for determining the status of Mtb within macrophages 
at a snapshot in time, it cannot account for any past bacterial killing.   
Thioglycollate-elicited peritoneal macrophages were infected with live/dead reporter Mtb 
prior to addition of uninfected CD45.1 congenic peritoneal macrophages.  Twenty hours later 
tetracycline was added to induce the GFP protein expression.  Cells were fixed and analyzed by 
confocal microscopy twenty four hours later, approximately 48 hours post infection.  Using these 
live/dead reporter Mtb, we find that fewer live or transcriptionally active Mtb were present 
within efferocytic (CD45.1) macrophages (Figures 4-8A,B).  After inhibiting efferocytosis, we 
found the same proportion of live Mtb within the CD45.1 macrophages as in the primary infected 
macrophages.  
Previously we reported that apoptosis is required for efferocytosis mediated control and 
that efferocytosis is required for subsequent suppression of Mtb growth in vitro (Chapter 3).  We 
surmised that apoptosis itself is not intrinsically bactericidal.  To further confirm these results we 
induced apoptotic death in live/dead Mtb infected macrophages.  80% of Mtb within apoptotic  102 
 
 
Figure 4-7.  Live/Dead reporter Mtb accurately reflect the metabolic state of Mtb. 
A.  Live/Dead Mtb following overnight incubation with 200ng/mL tetracycline.  “Live” Mtb are 
mCherry
+ (red) and GFP
+ (green) while “Dead” Mtb are mCherry
+.  B.  Primary human 
monocyte-derived Mφs were infected with Live/Dead H37Rv and were infected with MOI 1 for 
three days before treatment with rifampicin for one day. Bacterial burden was then ascertained 
by microscopy or serial dilution and CFU.  The ratio red:green (live:dead) pixels were averaged 
in untreated verses rifampicin treated wells and plotted as percent ‘live’ of control untreated 
wells.  The amount of red/green signal in the rifampicin group is 19.29% of the untreated.  For 
CFU, rifampicin treated macrophages had 20.94% of the bacteria present in untreated wells.   
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macrophages, as determined by characteristic fragmented nuclei, were alive (Figure 4-9).  80% 
of Mtb within non-apoptotic macrophages were alive as well.  Thus, the link between apoptosis 
and Mtb killing is not direct and efferocytosis accounts for the bactericidal effects associated 
with apoptosis.  We also found that the majority of the dead bacteria were found within LAMP1
+ 
compartments (Figure 4-10A,B).  Collectively, these data indicate that following efferocytosis, 
the efferocytic phagosome containing the infected apoptotic cell fuses with lysosomes, which are 
capable of killing Mtb. 
Discussion 
 
  A key component of Mtb’s virulence strategy is the ability to reside within an arrested 
phagosome.  Typically the bacterium excludes the fusion of lysosomes from the Mtb-containing 
phagosome and thus avoids damage and killing.  The Mtb-containing efferocytic phagosome is 
different.  Following apoptosis we have previously reported that Mtb-containing apoptotic blebs 
and apoptotic cells are engulfed by uninfected macrophages through the process of efferocytosis.  
We have found and characterized efferocytosed Mtb-infected apoptotic blebs  by TEM, thus 
confirming our earlier reports of efferocytosis of infected apoptotic cells.  The efferocytic 
phagosome containing Mtb with dead cell debris is vacuous and more closely resembles ingested 
apoptotic thymocytes than the primary infected bacterial phagosome.  Also, damaged Mtb were 
found along with digested cell debris, raising the possibility that the efferocytic phagosome fused 
with lysosomes.  To point, we found increased co-localization with lysosomal markers following 
efferocytosis over primary infection.  And using the novel live/dead Mtb reporter, following 
efferocytosis more Mtb is killed, and the killed Mtb are found within lysosomes, suggested that 
their killing and lysosomal fusion go hand- in-hand.  Thus we report here that efferocytosis is a  
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Figure 4-8.  Mtb are dead following efferocytosis 
A.  Dead Mtb within a CD45.1 originally uninfected thioglycollate-elicited peritoneal 
macrophage (pMφ) and alive within a primary infected pMφ 48 hours after co-culture and 24 
hours after GFP induction with 200ng/mL tetracycline.  Mtb-mCherry (red), Mtb-GFP (green), 
CD45.1 (far red/pseudocolor blue) and merge.  Dashed outline delineates CD45.2 primary 
infected macrophage.  B.  Quantification of (A).  Percentage of live (mCherry+GFP+) Mtb of 
total Mtb (mCherry+) in indicated pMφ population.  Uninfected pMφs pretreated with 10uM 
PGE2 prior to addition.  Isoniazid (1 µg/mL) was added immediately after co-culture.  150 Mtb 
were counted in triplicate per condition.  Data is representative of 3 experiments.  Error bars ± 
SEM, p ≤ 0.05, One-way ANOVA with Dunnet’s post-test. 
 
   105 
 
 
Figure 4-9.  Apoptosis does not impact Mtb viability 
Widefield image of live Mtb within an apoptotically dying cell.  GFP (green), mCherry (red), 
DNA/DAPI (UV/pseudocolor blue) and merge.  Thiogycollate-elicited peritoneal macrophages 
were infected with live/dead Mtb for 4 hours.  Uninternatlized bacteria were washed away and 
1µg/mL staurosporine and 200ng/mL tetracycline were added for 24 hours to induce apoptosis in 
the macrophages and GFP signal in the live bacteria.  Image is representative of 50 Mtb-infected 
apoptotic (fragmented nuclei
+) macrophages counted.   
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Figure 4-10.  Dead Mtb are found within LAMP1
+ vesicles 
A. “Live” (top) Mtb do not co-localize with LAMP1 as frequently as “Dead” (bottom) Mtb in 
bone marrow-derived macrophages (BMDMφs).  LAMP1 (far red/pseudocolor blue), GFP/live 
(green), mCherry/Mtb (red) and merge.  B.  Quantification of (A).  Percent LAMP1 co-
localization with “Live” or “Dead” Mtb of total “Live” or “Dead” Mtb in BMDMφs.  Data is 
representative of two experiments.   Error bars ± SEM, p ≤ 0.05.  Student’s T-test. 
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novel mechanism for bacterial killing that delivers Mtb to the caustic environment of the 
lysosomes.   
The actual mechanism of Mtb killing outlined here, lysosomal fusion, is well described to 
control Mtb.  IFNγ is perhaps the best known not just for iNOS upregulation, but for stimulating 
phagosome maturation that leads to more lysosomals fusing with the Mtb phagosome
11.  As we 
have reported earlier (Chapter 3) that IFNγ  pre-treatment does not enhance efferocytosis-
mediated control, we speculate that efferocytosis does not require an outside signal to facilitate 
lysosome fusion to the Mtb-containing efferocytic phagosome.   We do not envision that 
efferocytosis evolved to be antibacterial- it is a crucial function of all multicellular organisms 
charged with the task of dead cell removal.  In primitive organisms, such as C. elegans, 
effereocytosis is exclusively mediated by body cells, not ‘immune-type’ cells.  Thus efferocytosis’ 
primary function is dead cell removal, and microbial killing appears to be a fortunate side effect.  
This does not exclude the possibility that efferocytosis has since been adapted in macrophages 
especially as a potent means for microbial control.  In macrophages especially, the rate of 
acidification and acquisition of lysosomal proteins to the efferocytic phagosome is faster than 
phagocytosis of opsonized particles
24.    Simply, Mtb is killed along with destruction of the 
internalized apoptotic cell material.   
  Until further work is done characterizing the interactions of Mtb, its virulence factors and 
how they interact with host proteins, we can only speculate as to why Mtb can inhibit maturation 
of a primary phagosome but not the efferocytic phagosome.  We detected Mtb within apoptotic 
blebs,  within the characteristic spacious efferocytic phagosome.  We hypothesize that Mtb 
compartmentalized within an apoptotic cell within an efferocytic phagosome  is further 
segregated from the host macrophage and phagosomal maturation machinery.  While all Mtb’s 108 
 
effector molecules responsible for phagosome arrest are not known, it is reasonable to assume 
that many or all of them have limited access to their targets from behind these additional layers 
of membrane.  For one, Mtb’s lipidic effector molecules TDM and ManLAM may intercalate 
into the phagosome membrane to interfere with the transition from Rab5 to Rab7 and EEA1
3.  
Perhaps these molecules cannot access the phagosome membrane from within the apoptotic cell.  
Secreted  effector molecules, like SapM and proteins translocated by SecA2 may target host 
proteins in the cytosol
12, 25, 26.  The additional layer of membrane separating Mtb from the host 
phagosome membrane may act as a barrier restricting access to the cytosol.  It has been proposed 
that Mtb requires a tight-opposing phagosome membrane to transport it’s effectors into the 
cytosol to find their targets
27.  In this case, the vacuous efferocytic phagosome would prevent 
translocation of virulence factors.  Not only are Mtb virulence proteins associated with 
phagosome arrest prevented from acting on their host targets; bacterial proteins associated cell 
death induction are also sequestered.  It would be interesting to determine if macrophages that 
have taken up Mtb within efferocytic phagosomes are completely immune to other Mtb virulence 
strategies, such as MHC down-regulation and IFNγ unresponsiveness. 
  Alternatively, the proteins required for efferocytic phagosome maturation are distinct 
from phagosome maturation and Mtb cannot interfere with this different class of proteins.   
Phagosome maturation following the ingestion of either a free bacteria, particle or dead cell 
proceeds by exchanging Rab5 for Rab7
28.  This process, called Rab conversion, allows for the 
tethering and fusion of lysosomes through Rab7-RILP interaction
29.  Recently it has been 
described that novel Rab5 effectors, Mon1a/b and Czz1 may act exclusively on efferocytic 
phagosomes to link Rab5 activation with Rab7 recruitment
30.  Perhaps these proteins cannot be 
targeted by Mtb’s secreted virulence factors.  More work is required to completely understand 109 
 
how efferocytosis is capable of more efficiently delivering Mtb to lysosomes.  Many intracellular 
pathogens avoid destruction by avoiding lysosomes; either by translocation into the cytosol or by 
phagosome maturation arrest.  Perhaps efferocytosis of these pathogens could  lead to their 
destruction. 
 
Experimental Procedures 
Mice and macrophage isolation 
C57Bl/6 (CD45.2) and B6.SJL-Ptprc
aPepc
b/BoyJ (CD45.1) mice were purchased from Jackson 
Laboratories, and were kept and bread using standard humane animal husbandry protocols.  Mtb-
infected mice were housed under BSL3 conditions. Thioglycollate-elicited peritoneal 
macrophages were lavaged from peritoneal cavities 4-5 days following 3% IP thioglycollate 
injection.  Macrophages were isolated using CD11b microbeads and magnetic columns (Miltenyi 
Biotec) and cultured in 24 or 96 well dishes overnight prior to infection.  Resident peritoneal 
macrophages were lavaged from peritoneal cavities and selected based on CD11b
+CD19
-.  Bone 
marrow-derived macrophages were differentiated from bone marrow cells 7-10 days in RPMI 
supplemented with 20% L929 cell supernatant containing M-CSF.  Alveolar macrophages were 
lavaged from the lungs of mice with PBS.   
 
Confocal microscopy efferocytosis assay 
mCherry-H37Rv and live/dead-H37Rv were grown in the presence of 0.5ug/mL Hygromycin in 
7H9 media for 1 week prior to preparation as previously described
31.  GFP-H37Rv was grown in 
7H9.  Mφs from CD45.2 mice were cultured in 24 well dishes in triplicate per condition upon 
coverglass and dyed with Vybrant DiO (Invitrogen) as per manufacturer’s specifications prior to 110 
 
infection with mCherry-H37Rv or GFP-H37Rv for 4 hours at an MOI of 10 as described 
previously
31.  Bacteria were washed away and uninfected CD45.1 Mφs were added at 2x the 
number of infected Mφs.  Treatment conditions were added as appropriate: Caspase 3 inhibitor 
(CalBiochem), 10µM.  Uninfected macrophages were pre-treated with 10uM PGE2 for 4 hours 
prior to addition where indicated.  16-24 hours later cells were washed and stained with mouse 
monoclonal CD45.1 (Abcam) before affixing to microscopy slides with Prolong Gold plus DAPI 
(Invitrogen).  LAMP1 (Abcam) and LC3 (MBL) staining was done 16-24 hours post infection 
following fixation and TritonX permeabalization.  vATPase (Abcam) staining was done 16-24 
hours post infection following fixation and saponin permeabalization.  Lysotracker Red 
(Invitrogen) was added 16-24 hours post infection for 1 hour at 37
oC at 1uM prior to washing 
and fixation.  Tetracycline was added 16 hours post infection/addition of uninfected Mφs at 
200ng/mL and induced GFP expression for 24 hours in live/dead H37Rv-infected  Mφs.  
Conditions were analyzed in triplicate and for each replicate in each condition 100-300 Mtb were 
counted.  Images were taken using a Nikon TE2000-U inverted microscopy  
 
Transmission Electron microscopy 
Macrophages were grown in 6 well dishes and infected and treated as described above.  24 hours 
post infection cells were fixed with glutaraldehyde/paraformaldehyde/picric acid in sodium 
cacodylate buffer for 1 hour.  Cells were postfixed for 30 minutes in Osmium tetroxide/ 
Potassium ferrocyanide, washed in water and incubated in uranyl acetate for 30 minutes.  Cells 
were washed and dehydraded in alcohol, removed from culture dish in propuleneoxide, pelleted 
and infiltrated for 2 hours in propuleneoxide and TAAB Epon (Marivac).  Samples were 
embedded in TAAB Epon and polymerized at 60
oC for 48 hours.  60nM sections were cut on a 111 
 
Reichert Ultracut-S microtome, picked up onto copper grids and stained with lead citrate and 
examined using a TecnaiG
2 Spirit BioTWIN transmission electron microscopy and recorded with 
an AMT 2k CCD camera. 
 
Image Analysis 
Microscopy images were analyzed using Image J
32 and co-localization analysis macros or user-
generated pipelines in Cell Profiler
33.  Investigators were blinded during co-localization analysis.   
 
Statistical Analysis 
Statistical analysis and graphical output was done with GraphPad Prism.  One-way ANOVA with 
Dunnet’s post-test.  * = p≤0.05 
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Apoptosis and Mycobacterium tuberculosis control: a perspective 
The notion that apoptosis is directly mycobactericidal is deeply entrenched in the 
literature.  This fact is so taken for granted that it is stated in the introduction to many papers and 
reviews, despite no specific mechanism put forth to explain how this form of cell death is 
detrimental to the bacteria.  While no mechanism has been provided, several hypotheses exist to 
explain the observation that following apoptosis, Mycobacterium tuberculosis (Mtb) growth is 
suppressed.  It has been speculated that Mtb cannot grow and survive within an apoptotic bleb- 
that the nutrients for its survival are lacking
1.  Also, it has been assumed that without the 
macrophage phagosome niche, the bacteria cannot grow well.  Perhaps more reasonably, it has 
been assumed that apoptosis damages the bacteria, possibly through reactive oxygen species and 
nitrogen intermediates (ROS & RNI).  All three of these assertions have gone untested and are in 
many ways antithetical to other findings.  For the first instance, apoptotic blebs are rapidly 
removed by macrophages, both in vitro and in vivo.  This process of efferocytosis is well known 
and has a rich history of research.  Also to point, Mtb is a hardy slow-growing bacterium, and 
while an apoptotic bleb might not contain the full complement of Mtb’s preferred nutrients, the 
notion that Mtb could consume them all before the bleb is efferocytosed is untested.  Next, 
researchers have found Mtb growing outside the macrophage in caseous necrotic granulomas- so 
even in vivo Mtb does not need to reside within a macrophage or a phagosome.  Even in vitro, 
extracellular growth amongst necrotic macrophage debris is observed.  While the growth rates 
between intracellular and extracellular growth may be different, clearly Mtb can survive and 
grow in many different niches.  Finally, the notion that apoptosis might directly harm the 
bacteria lacks evidence.  During some forms of apoptotic cell death, reactive oxygen species are 
released.   Then again, this is true of necrotic cell death as well.  Mtb employs many strategies to 117 
 
survive reactive intermediate insult, and while the bacterium is not completely protected, there is 
no evidence that this type for ROS/RNI is damaging.  Thus we felt that the possibility that 
apoptosis directly damages Mtb, or limits its growth is unlikely. 
The dichotomy between apoptosis and necrosis during Mtb infection is old.  While 
current thinking dictates that necrosis is dominant, early studies favored apoptosis as the primary 
mode of cell death during active disease in the granuloma
2.  Following up on this observation, 
researchers sought to understand what the consequences of apoptosis is on the bacilli.  First, 
BCG infected macrophages were treated with ATP to induce apoptosis and hydrogen peroxide to 
induce necrosis
3.  The apoptosis condition was associated with decreased bacterial growth.  
Furthermore, Fas ligand treatment of human macrophages infected with Mtb also suppressed 
bacterial growth
4.  However, in the BCG study efferocytosis of BCG-infected macrophages was 
observed by electron microscopy.  In the Mtb study, less than half of the infected macrophages 
were apoptotic following Fas treatment, allowing plenty of unaffected macrophages to 
efferocytose the dying cells.  Thus, even these oft cited studies do not completely and directly 
address the antibacterial mechanism of Mtb control following apoptosis.  Therefore, we 
remained skeptical of apoptosis’ bactericidal activity. 
There are a few reports that hint at efferocytosis might be responsible for Mtb control 
following apoptosis.  For one, Fratazzi et al found that M. avium growth is suppressed following 
apoptosis, but only if uninfected macrophages are present
5.  The authors do not speculate as to 
why this is true in this manuscript, but the same authors later speculate that the control exerted 
by uninfected macrophages could be exerted by engulfment of the Mtb-infected apoptotic cells
1.  
However, no experiments were done to directly test this observation and the notion that 
apoptosis is bactericidal still prevailed in the literature.  Additionally, it was found that addition 118 
 
of uninfected macrophages to Mtb-infected macrophages suppressed growth, but only if the 
macrophages were added shortly after infection
6.  Waiting for 24 hours before macrophage 
addition had no impact on bacterial growth.  And in this model, there was robust apoptosis.  
Presumably, waiting 24 hours prior to macrophage addition caused the apoptotic cells to 
succumb to secondary necrosis.  Thus the inkling that efferocytosis might be responsible for Mtb 
control has existed for some time in the field, however it was never explicitly stated, or directly 
tested.   
One recent finding suggested that efferocytosis is inhibited during Mtb infection, and that 
the control mediated by uninfected macrophage co-culture is due to a secreted small molecule
7.  
A major difference between these models is the bacterial burden.  We rely on infections that 
result in 1-5 bacteria, unclumped and in individual phagosomes inside each macrophage, while 
Hartman et al aimed for a much higher burden that induces lysosome-dependent atypical cell 
death.  As many Mtb researchers will agree, the bacterial burden has a significant effect on the 
behavior and phenotype of the infected macrophage.  Our work does not exclude the possibility 
of mechanisms other than efferocytosis at play during uninfected macrophage co-culture; 
however our evidence for efferocytosis and its consequences are robust.  Thus we present for the 
first time, efferocytosis as a mechanism of bacterial control. 
Summary of findings 
Despite previous reports, we found that apoptosis is not intrinsically mycobactericidal.  
First, we found that there is a significant amount of apoptosis following Mtb infection.  We 
speculate that much of the necrotic death observed by others is a consequence of the in vitro 
system that does not allow for efficient efferocytosis; thus apoptotic cells fall apart by secondary 119 
 
necrosis and confound analysis.  We then developed an uninfected macrophage co-culture model 
to study the fate of Mtb-infected macrophages.  We found that uninfected macrophages are 
capable of engulfing Mtb-infected apoptotic macrophages.  This was true in multiple 
macrophage types tested as well as in vivo, specifically in the lung.  Next we found that 
uninfected macrophage co-culture, a condition that promotes efferocytosis, controls Mtb growth 
in in vitro culture.  Again, this was true of all macrophage types tested, specifically alveolar 
macrophages.  We found that apoptosis is required for this control, as inhibition of efferocytosis 
not only blocked efferocytosis, but also blocked uninfected macrophage co-culture control of 
Mtb growth.  Blocking efferocytosis itself by specifically blocking the ‘efferocytosis receptor’, 
TIM4 abrogated the uninfected macrophage co-culture system’s ability to control Mtb growth.  
Then, we asked how efferocytosis could limit Mtb growth.  We found that Mtb present in 
efferocytic phagosomes are very different structures than traditional bacterial phagosomes.  In 
fact, these structures fuse with lysosomes much more readily than the traditional Mtb 
phagosome: Mtb within efferocytic phagosomes co-localize with the vATPase, LAMP1 and are 
acidified.  Lastly we found that Mtb is killed only after uninfected macrophages engulf the 
infected apoptotic cell and fuse the efferocytic phagosome with lysosomes. Thus, Mtb is 
destroyed along with the apoptotic cell material.  Simply put, apoptotic Mtb-infected 
macrophages are engulfed and Mtb is killed by phagosome maturation (Figure 5-1).  
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Figure 5-1. Model of efferocytosis-mediated control 
The Mtb-infected macrophage dies.  An Mtb-containing bleb is engulfed by a neighboring 
macrophage via efferocytosis.  Mtb cannot inhibit the maturation of the efferocytic phagosome, 
as lysosomes fuse delivering their microcidal compounds.  Ultimately, Mtb is killed as the 
apoptotic cell material is destroyed. 
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Implications 
 This report has focused on the role of macrophage apoptosis as an innate response 
following Mtb infection.  However, the killing of infected cells is an important component of the 
CD8
+ T cell response to tuberculosis
8. T cells can induce death in target cells via the release of 
cytotoxic granules containing granzymes and perforin or through the engagement of surface 
receptors containing death domains such as CD95/95L
9,10.  Both of these pathways lead to 
apoptotic death in the target cells.  We envision that capacity of CTL to kill infected cells 
restricts bacterial growth indirectly since the induction of apoptosis in the infected cells will 
facilitate their engulfment by uninfected macrophages recruited to inflammatory foci.  One could 
speculate that the benefit of CTL during infection is not to impact microbial viability by 
eliminating their replicative niche, but to allow for efferocytosis-mediated microbial killing. 
The relative efficiency of efferocytosis will depend on the microenvironment.  Some 
inflammatory signals, such as abundant TNF, can hamper efferocytosis
11.  This could impair 
efferocytosis and lead to greater secondary necrosis.  If efferocytosis is inhibited during active 
Mtb infection, pharmacologically releasing this inhibition could benefit the infected individual in 
two ways.  First, tuberculosis is a disease of rampant cell death, inflammation and tissue 
destruction.  Efferocytosis would be key in maintaining proper lung tissue architecture during 
disease and minimizing the development of immunopathology.  Second, enhancing efferocytosis 
may restrict bacterial replication and prevent recrudescence of infection.  In contrast, 
efferocytosis might play an important role during the maintenance of latency or even in aborting 
infection before it becomes established.  Additionally, once can envision that during different 
stages of infection apoptosis or necrosis might be more dominant, further influencing the amount 122 
 
of efferocytosis.  However, the changing dynamics of cell death in vivo during infection is not 
known.   
This study focused on the effect of uninfected macrophages engulfing infected apoptotic 
macrophages; however we found that Mtb-infected macrophages are fully capable of engulfing 
apoptotic cells (Chapter 2).  We did not directly test this scenario, however CD45.1 macrophages 
were occasionally found with evidence of both efferocytosis and secondary infection.  As it is 
impossible to know what event happened first: efferocytosis or secondary infection, we did not 
follow up on this further.  However, in these situations we envision that the efferocytosed Mtb 
will be killed via the mechanisms outlined above, while the phagocytosed Mtb will be unharmed.  
This is based on the fact that phagosomes are autonomous: what happens to one does not happen 
to the other
12,13.  Thus efferocytosis could still mediate bacterial control, even in the absence of 
infected macrophages at the site of infection. 
Elucidating the different stages of immunity when efferocytosis is crucial for bacterial 
control will require experimental approaches that are capable of detecting and blocking 
efferocytosis in vivo.  This would be exceedingly difficult, given the redundancy of 
‘efferocytosis receptors’.  Additionally, most work on efferocytosis in vivo focuses on 
transferring apoptotic targets as this enables easier and faster read-outs.  However, more models 
are under development that could facilitate in vivo study of efferocytosis during pulmonary 
tuberculosis infection
14,15.  It will also be important to determine whether efferocytosis is 
subverted by pathogens to evade immunity.  For example, Leishmania employ neutrophil 
apoptosis and subsequent efferocytosis as a mechanism of establishing infection within 
macrophages 
16,17.  Indeed, some pathogens might rely on uptake of infected dying cells to 
spread the infection, as is the case in M. marinum infection of zebrafish embryos 
18.  123 
 
Efferocytosis of influenza-infected cells is associated with viral control
19,20.   Efferocytosis may 
control or exacerbate many infectious diseases and it will be important to explore how 
macrophages contribute to microbial immunity by executing this vital ‘house-keeping’ function.  
 
Future Directions 
Macrophages are not the sole efferocytic cell, although they contribute most to dead cell 
clearance.  Endothelial tissue cells and fibroblasts can engulf their dying neighbors.  Perhaps 
most notably, dendritic cells (DCs) efferocytose apoptotic cells.  Given dendritic cells’ important 
role in altering and tailoring the adoptive immune response to tuberculosis, further study 
focusing on dendritic cells ability to kill Mtb following efferocytosis is needed. 
 Efferocytosis of apoptotic cells and cell debris by DCs is responsible for cross 
presentation of antigens on MHC class I normally hidden from CD8 T cell surveillance
21,22.  
Apoptosis of Mtb infected apoptotic macrophages results in uptake and cross presentation by 
dendritic cells
23.  This results in the development of a more robust immune response as well as 
bacterial control
24.  However, what is not known is whether Mtb taken up by DCs via 
efferocytosis are killed.  Dendritic cells mature their phagosomes at a much slower rate and not 
as robustly as macrophages
25.  Additionally, DCs possess fewer degradative enzymes in their 
lysosomes than macrophages
26.  Perhaps DCs are thus less equipped to kill Mtb following 
efferocytosis.  Dendritic cells bring Mtb from the lung to the lymph node to induce T cell 
responses
27,28.  However, this is responsible for dissemination and spread of the infection.  
Whether DCs trafficking Mtb to distal sites are directly infected or have taken up Mtb via 
efferocytosis, is not known.  Recently, the CD103
+ subset of DCs in the lungs, separate from the 
classical CD11c
+ subset was found to primarily engulf apoptotic cells and present antigen
15.  124 
 
Discerning which DC subsets participate in efferocytosis during Mtb infection, compared with 
the DC subsets responsible for priming protective T cell responses could inform the design more 
robust vaccines.   Understanding the relative merits of efferocytosis of Mtb-infected apoptotic 
macrophages by DCs to induce T cell responses or Mtb death is important.   If there is a 
difference in killing capacity of DCs compared to macrophages following efferocytosis we could 
discern which components of the macrophage lysosomal machinery are key to Mtb killing.   
Cell death is an ever expanding field, and microbe-induced cell death is incredibly 
complex.  We speculate that efferocytosis of apoptotic infected cells allows for the further 
compartmentalization of Mtb, and thus more efficient lysosomal fusion and killing once in the 
efferocytic phagosome.  And as necrosis is associated with increased bacterial growth and 
survival, we speculate that the uptake of a bacterium within necrotic cell debris (without an intact 
plasma membrane) would have a similar effect as phagocytosing free bacteria.  However, early 
necrotic cells are described as possessing an intact membrane and can be cleared via the same 
mechanisms as apoptotic cells
29,30.  In fact, our data would suggest that the only requirement for 
efferocytosis-mediated control would be for the bacterium to be encased within an additional 
membrane.  Thus alternative forms of cell death: pyroptosis and caspase-independent cell death 
might have a similar end result.   
Ultimately, the study of efferocytosis of infected cells is a brand new field, with much to 
be learned.  This study provides a mechanism for the long held observation that apoptosis 
attenuates tuberculosis and perhaps other pathogens as well.   
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